Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - XERIUM TECHNOLOGIES INCcopyofcpxrm-ex31_22015q3.htm
EX-32.2 - EXHIBIT 32.2 - XERIUM TECHNOLOGIES INCcopyofcpxrm-ex322_2015q3.htm
EX-32.1 - EXHIBIT 32.1 - XERIUM TECHNOLOGIES INCcopyofhbxrm-ex321_2015q3.htm
EX-31.1 - EXHIBIT 31.1 - XERIUM TECHNOLOGIES INCcopyofhbxrm-ex31x12015q3.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ________________________ 
FORM 10-Q
________________________
ý
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2015
Or
¨
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from             to             
Commission File Number 001-32498
 ________________________ 
Xerium Technologies, Inc.
(Exact name of registrant as specified in its charter)
 ________________________ 
 
DELAWARE
42-1558674
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
 
 
14101 Capital Boulevard
Youngsville, North Carolina
27596
(Address of principal executive offices)
(Zip Code)
(919) 526-1400
(Registrant’s telephone number, including area code)


(Former name, former address and former fiscal year, if changed since last report)
 ________________________ 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
 
  £
 
 
 
Accelerated filer
 
  x
Non-accelerated filer
 
  £
 
(Do not check if a smaller reporting company)
 
Smaller reporting company
 
  £
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).    Yes  ¨    No  ý
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.    Yes  ý    No  ¨
The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of November 2, 2015 was 15,739,259
 



TABLE OF CONTENTS
 

2



PART I. FINANCIAL INFORMATION
ITEM 1.
UNAUDITED FINANCIAL STATEMENTS

Xerium Technologies, Inc.
Condensed Consolidated Balance Sheets
(Dollars in thousands and Unaudited)
 
September 30, 2015
 
December 31,
2014
ASSETS
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
10,704

 
$
9,517

Accounts receivable, net
77,813

 
83,069

Inventories, net
71,803

 
83,550

Prepaid expenses
8,275

 
8,472

Other current assets
16,118

 
15,714

Total current assets
184,713

 
200,322

Property and equipment, net
296,570

 
303,617

Goodwill
61,176

 
61,927

Intangible assets
9,126

 
11,707

Non-current deferred tax asset
9,555

 
10,662

Other assets
9,098

 
5,809

Total assets
$
570,238

 
$
594,044

LIABILITIES AND STOCKHOLDERS’ DEFICIT
 
 
 
Current liabilities:
 
 
 
Notes payable
$
6,742

 
$
244

Accounts payable
37,972

 
41,827

Accrued expenses
57,994

 
56,109

Current maturities of long-term debt
10,887

 
4,406

Total current liabilities
113,595

 
102,586

Long-term debt, net of current maturities
466,687

 
460,840

Liabilities under capital leases
5,067

 
3,945

Non-current deferred tax liability
7,891

 
10,416

Pension, other post-retirement and post-employment obligations
71,150

 
80,471

Other long-term liabilities
13,099

 
9,896

Commitments and contingencies


 


Stockholders’ deficit
 
 
 
Preferred stock, $0.001 par value, 1,000,000 shares authorized; no shares outstanding as of September 30, 2015 and December 31, 2014

 

Common stock, $0.001 par value, 20,000,000 shares authorized; 15,739,259 and 15,560,627 shares outstanding as of September 30, 2015 and December 31, 2014, respectively
16

 
16

Paid-in capital
429,445

 
428,880

Accumulated deficit
(415,123
)
 
(417,068
)
Accumulated other comprehensive loss
(121,589
)
 
(85,938
)
Total stockholders’ deficit
(107,251
)
 
(74,110
)
Total liabilities and stockholders’ deficit
$
570,238

 
$
594,044



3


Xerium Technologies, Inc.
Consolidated Statements of Operations
(Dollars in thousands, except per share data and unaudited)
 
    
 
Three Months ended September 30,
 
Nine Months ended September 30,
 
2015
 
2014
 
2015
 
2014
Net Sales
$
117,739

 
$
138,858

 
$
361,896

 
$
411,965

Costs and expenses:
 
 
 
 
 
 
 
Cost of products sold
71,252

 
83,364

 
217,413

 
248,954

Selling
15,889

 
18,195

 
48,645

 
55,362

General and administrative
14,370

 
14,133

 
40,261

 
43,337

Research and development
1,841

 
1,909

 
5,695

 
5,899

Restructuring
5,001

 
3,466

 
12,734

 
15,712

 
108,353

 
121,067

 
324,748

 
369,264

Income from operations
9,386

 
17,791

 
37,148

 
42,701

Interest expense, net
(9,775
)
 
(9,412
)
 
(28,144
)
 
(26,985
)
Foreign exchange gain (loss)
2,059

 
367

 
2,150

 
(818
)
Income before provision for income taxes
1,670

 
8,746

 
11,154

 
14,898

Provision for income taxes
(755
)
 
(29,218
)
 
(9,209
)
 
(33,440
)
Net income (loss)
$
915


$
(20,472
)

$
1,945


$
(18,542
)
Comprehensive loss
$
(11,012
)
 
$
(41,003
)
 
$
(33,706
)
 
$
(39,482
)
Net income (loss) per share:
 
 
 
 
 
 
 
Basic
$
0.06

 
$
(1.32
)
 
$
0.12

 
$
(1.20
)
Diluted
$
0.06

 
$
(1.32
)
 
$
0.12

 
$
(1.20
)
Shares used in computing net income (loss) per share:
 
 
 
 
 
 
 
Basic
15,667,103

 
15,475,836

 
15,595,793

 
15,426,125

Diluted
16,567,070

 
15,475,836

 
16,440,525

 
15,426,125

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


4


Xerium Technologies, Inc.
Consolidated Statements of Cash Flows
(Dollars in thousands and unaudited)
 
 
Nine Months ended September 30,
 
2015
 
2014
Operating activities
 
 
 
Net income (loss)
$
1,945

 
$
(18,542
)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
 
 
 
Stock-based compensation
2,690

 
1,858

Depreciation
21,397

 
24,950

Amortization of intangibles
228

 
1,230

Deferred financing cost amortization
2,641

 
2,409

Foreign exchange gain on revaluation of debt
(2,115
)
 
(340
)
Deferred taxes
(1,571
)
 
1,509

Asset impairment
1,178

 
277

Gain on disposition of property and equipment
(85
)
 
(4
)
Provision for doubtful accounts
857

 
284

Change in assets and liabilities which provided (used) cash:
 
 
 
Accounts receivable
(2,789
)
 
(5,047
)
Inventories
3,640

 
(7,897
)
Prepaid expenses
(717
)
 
120

Other current assets
(2,025
)
 
1,223

Accounts payable and accrued expenses
5,133

 
3,587

Deferred and other long-term liabilities
(5,551
)
 
(4,300
)
Net cash provided by operating activities
24,856

 
1,317

Investing activities
 
 
 
Capital expenditures
(40,376
)
 
(33,666
)
Proceeds from disposals of property and equipment
104

 
163

Net cash used in investing activities
(40,272
)
 
(33,503
)
Financing activities
 
 
 
Proceeds from borrowings
64,187

 
73,579

Principal payments on debt
(45,573
)
 
(44,834
)
Payment of financing fees
(18
)
 
(1,398
)
Payment of obligations under capital leases
(887
)
 
(634
)
Net cash provided by financing activities
17,709

 
26,713

Effect of exchange rate changes on cash flows
(1,106
)
 
(430
)
Net increase (decrease) in cash
1,187

 
(5,903
)
Cash and cash equivalents at beginning of period
9,517

 
25,716

Cash and cash equivalents at end of period
$
10,704

 
$
19,813

 
 
 
 
Non-cash capitalized lease asset and liability
$
1,122

 
$
4,468

Accrued construction in process
$
1,952

 
$
2,400




5


Xerium Technologies, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
(Dollars in thousands, except per share data)
1. Description of Business and Significant Accounting Policies
Description of Business

Xerium Technologies, Inc. (the "Company") is a leading global provider of industrial consumables and mechanical services used in the production of paper, paperboard, building products and nonwoven materials. Its operations are strategically located in the major paper-making regions of the world, including North America, Europe, South America and Asia-Pacific.
Basis of Presentation
The accompanying unaudited condensed consolidated interim financial statements at September 30, 2015 and for the three and nine months ended September 30, 2015 and 2014 include the accounts of the Company and its wholly-owned subsidiaries and have been prepared in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) for interim financial reporting and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, such financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. The interim results presented herein are not necessarily indicative of the results to be expected for the entire year. In management’s opinion, these unaudited condensed consolidated interim financial statements contain all adjustments of a normal recurring nature necessary for a fair presentation of the financial statements for the interim periods presented. These unaudited condensed consolidated interim financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2014 as reported on the Company's Annual Report on Form 10-K filed on March 4, 2015.
Accounting Policies
Inventories, net
Inventories are generally valued at the lower of cost or market using the first-in, first-out (FIFO) method. Raw materials are valued principally on a weighted average cost basis. The Company’s work in process and finished goods are specifically identified and valued based on actual inputs to production. Provisions are recorded as appropriate to write-down obsolete and excess inventory to estimated net realizable value. The process for evaluating obsolete and excess inventory often requires management to make subjective judgments and estimates concerning future sales levels, quantities and prices at which such inventory will be able to be sold in the normal course of business, while considering the general aging of inventory and factoring in any new business conditions.
The components of inventories are as follows at:
 
 
September 30,
2015
 
December 31,
2014
Raw materials
$
12,383

 
$
18,018

Work in process
26,055

 
28,756

Finished goods (includes consigned inventory of $6,985 at September 30, 2015 and $8,582 at December 31, 2014)
39,546

 
43,072

Inventory allowances
(6,181
)
 
(6,296
)
 
$
71,803

 
$
83,550

Goodwill
The Company accounts for goodwill and other intangible assets in accordance with ASC Topic 350, Intangibles—Goodwill and Other Intangible Assets (“Topic 350”). Topic 350 requires that goodwill and intangible assets that have indefinite lives not be amortized, but instead, must be tested for impairment at least annually or whenever events or business conditions warrant. During the nine months ended September 30, 2015, the Company evaluated events and business conditions to determine if a test for an impairment of goodwill was warranted. No such events or business conditions took place during this period, therefore no test was determined to be warranted at September 30, 2015.
Warranties
The Company offers warranties on certain roll products that it sells. The specific terms and conditions of these warranties vary depending on the product sold, the country in which the product is sold and arrangements with the customer. The Company

6


estimates the costs that may be incurred under its warranties and records a liability in Accrued Expenses on its Consolidated Balance Sheet for such costs. Factors that affect the Company’s warranty liability include the number of units sold, historical and anticipated rates of warranty claims, cost per claim and new product introduction. The Company periodically assesses the adequacy of its recorded warranty claims and adjusts the amounts as necessary. The table below represents the changes in the Company’s warranty liability for the nine months ended September 30, 2015 and 2014:
 
Beginning Balance
 
Charged to
 Cost
of Sales
 
Effect of Foreign
Currency
Translation
 
Deduction
from
Reserves
 
Ending Balance
Nine Months Ended September 30, 2015:
$
2,685

 
$
1,184

 
$
(144
)
 
$
(1,580
)
 
$
2,145

Nine Months Ended September 30, 2014:
$
1,629

 
$
1,694

 
$
(86
)
 
$
(867
)
 
$
2,370


Net (Loss) Income Per Common Share
Net (loss) income per common share has been computed and presented pursuant to the provisions of ASC Topic 260, Earnings per Share (“Topic 260”). Net (loss) income per share is based on the weighted-average number of shares outstanding during the period. As of September 30, 2015 and 2014, the Company had outstanding restricted stock units (“RSUs”), deferred stock units (“DSUs”) and options.
The following table sets forth the computation of basic and diluted weighted-average shares:
 
Three Months ended September 30,
 
Nine Months ended September 30,
 
2015
 
2014
 
2015
 
2014
Weighted-average common shares outstanding–basic
15,667,103

 
15,475,836

 
15,595,793

 
15,426,125

Dilutive effect of stock-based compensation awards outstanding
899,967

 

 
844,732

 

Weighted-average common shares outstanding–diluted
16,567,070

 
15,475,836

 
16,440,525

 
15,426,125

The following table sets forth the aggregate of the dilutive securities that were outstanding in the three and nine months ended September 30, 2015 and 2014, but were not included in the computation of diluted earnings per share because the impact would have been anti-dilutive:
 
Three Months ended September 30,
 
Nine Months ended September 30,
 
2015
 
2014
 
2015
 
2014
Anti-dilutive securities
24,002

 
1,313,627

 
20,237

 
1,313,627

Impairment
The Company reviews its long-lived assets that have finite lives for impairment in accordance with ASC Topic 360, Property, Plant, and Equipment (“Topic 360”). This topic requires that companies evaluate the fair value of long-lived assets based on the anticipated undiscounted future cash flows to be generated by the assets when indicators of impairment exist to determine if there is impairment to the carrying value. Any change in the carrying amount of an asset as a result of the Company's evaluation has been recorded in either restructuring expense, if it was a result of the Company's restructuring activities, or general and administrative expense for all other impairments in the consolidated statements of operations. For the nine months ended September 30, 2015 and 2014, the Company had $1.0 million and $0.3 million of impairment charges included in restructuring expense. Impairment charges associated with restructuring are discussed in Note 7 "Restructuring Expense".

New Accounting Pronouncements

In May of 2014, the FASB issued Accounting Standard Update No. 2014-09 Revenue from Contracts with Customers ("ASU 2014-09"). ASU 2014-09 requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company identify the contract with the customer, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract and recognize revenue when it satisfies the performance obligations. The Company will also be required to disclose information regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. ASU

7


2014-09 is required to be adopted in January of 2018. Retrospective application is required either to all periods presented or with the cumulative effect of initial adoption recognized in the period of adoption. The Company is in the process of evaluating this accounting standard update.

In April of 2015, the FASB issued Accounting Standard Update No. 2015-03 Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs ("ASU 2015-03"). ASU 2015-03 requires debt issuance costs related to a recognized debt liability be presented on the balance sheet as a direct deduction from the carrying value of the debt liability, consistent with debt discounts. ASU 2015-03 is required to be adopted in January of 2016. The Company will adopt this pronouncement at December 31, 2015, and believes that the adoption of ASU 2015-03 will not have a material impact on its consolidated financial statements.
2. Derivatives and Hedging
Risk Management Objective of Using Derivatives
The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. From time to time, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known cash amounts, the value of which are determined by interest rates or foreign exchange rates.
Cash Flow Hedges of Interest Rate Risk
From time to time, the Company uses interest rate derivatives to add stability to interest expense and to manage its exposure to interest rate movements. However, at September 30, 2015, the Company had no interest rate swaps.
Non-designated Hedges of Foreign Exchange Risk
Derivatives not designated as hedges are not speculative and are used to manage the Company’s exposure to foreign exchange rates, but do not meet the strict hedge accounting requirements of ASC Topic 815. Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings.
The Company, from time to time, may enter into foreign exchange forward contracts to fix currencies at specified rates based on expected future cash flows to protect against the fluctuations in cash flows resulting from sales denominated in foreign currencies. Additionally, to manage its exposure to fluctuations in foreign currency on intercompany balances and certain purchase commitments, the Company from time to time may use foreign exchange forward contracts.
As of September 30, 2015 and December 31, 2014, the Company had outstanding derivatives that were not designated as hedges in qualifying hedging relationships. The value of these contracts is recognized at fair value based on market exchange forward rates and is recorded in other assets or other liabilities on the Consolidated Balance Sheets. The following represents the fair value of these derivatives at September 30, 2015 and December 31, 2014 and the change in fair value included in foreign exchange gain in the three and nine months ended September 30, 2015 and 2014:
 
September 30, 2015
 
December 31, 2014
Fair value of derivative asset (liability)
$
237

 
$
(524
)
 
Three Months Ended September 30, 2015:
 
Three Months Ended September 30, 2014:
Change in fair value of derivative included in foreign exchange loss
$
(743
)
 
$
(123
)
 
Nine Months Ended September 30, 2015
 
Nine Months Ended September 30, 2014
Change in fair value of derivative included in foreign exchange loss
$
(2,197
)
 
$
(1,328
)
The following represents the notional amounts of foreign exchange forward contracts at September 30, 2015:
 
 
Notional Sold
 
Notional Purchased  

Non-designated hedges of foreign exchange risk
$
5,212

 
$
(38,814
)

8


Fair Value of Derivatives Under ASC Topic 820
ASC Topic 820, Fair Value Measurements and Disclosures (“Topic 820”), emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, Topic 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs including fair value of investments that do not have the ability to redeem at net asset value as of the measurement date, or during the first quarter following the measurement date. The derivative assets or liabilities are typically based on an entity’s own assumptions, as there is little, if any, market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and the Company considers factors specific to the asset or liability. The Company determined that its derivative valuations, which are based on market exchange forward rates, fall within Level 2 of the fair value hierarchy.
                                                                        
3. Long term Debt
At September 30, 2015 and December 31, 2014, long term debt consisted of the following:
 
September 30, 2015
 
December 31, 2014
Senior secured term loan facility, payable quarterly, U.S. Dollar denominated–LIBOR
(minimum 1.25%) plus 5.0% (6.25%) net of $0.7 million discount. Matures May of 2019.
$
224,475

 
$
226,052

Senior Notes (Unsecured), payable semi-annually–U.S. Dollar denominated interest rate fixed at 8.875%. Matures June of 2018.
236,410

 
236,410

Notes payable, working capital loan, variable interest rate at 1.75%. Matures June 30, 2016, with one-year rollover option.
6,742

 
244

Fixed asset loan contract, variable interest rate of 5.78%. Matures June of 2020.
7,497

 

Other debt
9,192

 
2,784

Total debt
484,316

 
465,490

Less current maturities of long term debt and notes payable
17,629

 
4,650

Total long term debt
$
466,687


$
460,840

On May 17, 2013, the Company entered into a Credit and Guaranty Agreement for a $200.0 million term loan credit facility (the “Term Credit Facility”), net of a discount of $1.0 million, among the Company, certain direct and indirect U.S. subsidiaries of the Company as guarantors and certain financial institutions. The Company also entered into a Revolving Credit and Guaranty Agreement originally for a $40.0 million asset-based revolving credit facility subject to a borrowing base among Xerium Technologies, Inc., as a US borrower, Xerium Canada Inc., as Canadian borrower, certain direct and indirect U.S. subsidiaries of the Company as guarantors and certain financial institutions (the "Domestic Revolver"). On March 3, 2014, the Company entered into an amendment to the Revolving Credit and Guaranty Agreement (as amended, the “ABL Facility,” and collectively with the Term Credit Facility, the “Credit Facility”) to add the Company's German subsidiaries as European Borrowers (the "European Borrowers") and to provide for an additional $15 million European asset-based revolving credit facility subject to a European borrowing base (the "European Revolver"), increasing the facility limit under the ABL Facility to $55.0 million.
On August 18, 2014, the Company entered into the Second Amendment to Credit and Guaranty Agreement (the “Second Amendment”). Under the Second Amendment, the Company borrowed an additional $30.0 million by utilizing the Incremental Facility. The $30.0 million in additional borrowings was used to finance a tax amnesty payment in Brazil. The Second Amendment made no changes to the repayment and other previously disclosed terms of the Credit Facility.
The Credit Facility contains certain customary covenants that, subject to exceptions, restrict the Company's ability to, among other things:

9


declare dividends or redeem or repurchase equity interests;
prepay, redeem or purchase debt;
incur liens and engage in sale-leaseback transactions;
make loans and investments;
incur additional indebtedness;
amend or otherwise alter debt and other material agreements;
make capital expenditures in excess of $42 million per fiscal year, subject to adjustment;
engage in mergers, acquisitions and asset sales;
transact with affiliates; and
engage in businesses that are not related to the Company's existing business.

On July 17, 2015 (the "Closing Date"), Xerium China, Co., Ltd. ("Xerium China"), a wholly-owned subsidiary of the Company entered into and closed a Fixed Assets Loan Contract (the "Loan Agreement") with the Industrial and Commercial Bank of China Limited, Shanghai-Jingan Branch (the “Bank”) with respect to a RMB 58.5 million loan, which was approximately $9.4 million USD on July 17, 2015. The loan is secured by pledged machinery and equipment of Xerium China and guaranteed by Xerium Asia Pacific (Shanghai) Limited and Stowe Woodward (Changzhou) Roll Technologies Co. Ltd., which are wholly-owned subsidiaries of the Company, pursuant to guarantee agreements (the "Guarantee Agreements"). Interest on the outstanding principal balance of the loan accrues at a benchmark rate plus a margin. The benchmark rate is the benchmark interest rate as published by the People's Bank of China, which was 5.25% on June 28, 2015. The margin is set at 10% of the benchmark rate for the entire loan period, with the current interest rate calculated at 5.78%. The interest rate will be adjusted every 12 months during the term of the loan, based on the benchmark interest rate adjustment. Interest under the loan is payable quarterly in arrears. Principal on the loan is to be repaid in part every six months following the Closing Date, in accordance with a predetermined schedule set forth in the Loan Agreement. Proceeds of the Loan will be used by Xerium China to purchase production equipment. The Loan Agreement contains certain customary representations and warranties and provisions relating to events of default.
On November 3, 2015, the Company refinanced its existing ABL Facility and entered into a new Revolving Credit and Guaranty Agreement (as amended, the "New ABL Facility") with one of its existing ABL lenders, JPMorgan Chase Bank, N.A.   Under the New ABL Facility, JPMorgan will become the lead domestic agent and will continue as the European agent.  The amount of the ABL Facility will continue to provide aggregate availability of $55 million and the collateral pledged thereunder will also remain the same, however the New ABL Facility provides (1) increased flexibility for operations; (2) an extended maturity date of November, 2020; and (3) lower interest rates.
As of September 30, 2015, the outstanding balance of the Company's term debt under its Credit Facility and Notes was $460.9 million, which is net of a $0.7 million discount. In addition, as of September 30, 2015, an aggregate of $33.0 million is available for additional borrowings. This availability represents a borrowing base of $44.6 million less $11.6 million of that facility committed for letters of credit or additional borrowings.
As of September 30, 2015 and December 31, 2014, the carrying value of the Company’s debt was $484.3 million and $465.5 million, respectively, and its fair value was approximately $486.7 million and $478.2 million, respectively. The Company determined the fair value of its debt utilizing significant other observable inputs (Level 2 of the fair value hierarchy).

Capitalized Lease Liabilities

As of September 30, 2015, the Company had capitalized lease liabilities totaling $5.1 million. These amounts represent the lease on the corporate headquarters and certain other software licensing, vehicle and office equipment capitalized lease arrangements.
4. Income Taxes

The Company utilizes the liability method for accounting for income taxes in accordance with ASC Topic 740, Income Taxes (“Topic 740”). Under Topic 740, deferred tax assets and liabilities are determined based on the difference between their financial reporting and tax basis. The assets and liabilities are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reduces its deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. In making this determination, the Company evaluates all available information including the Company’s financial position and results of operations for the current and preceding years, as well as any available projected information for future years.

10


For the three and nine months ended September 30, 2015, the provision for income taxes was $755 and $9,209 as compared to $29,218 and $33,440 for the three and nine months ended September 30, 2014. The decrease in tax expense in the three months ended September 30, 2015, was primarily attributable to a $1,809 release of valuation allowance against Australian deferred tax assets along with decreased earnings in 2015, compared to a $25,298 tax provision recorded in 2014 related to settling a tax assessment in Brazil. The decrease in tax expense in the nine months ended September 30, 2015, was primarily attributable to a release of valuation allowance against Australian deferred tax assets partially offset by an increase in the unrecognized tax benefit due to the effects of income tax audits in 2015, compared to a tax provision recorded in 2014 related to settling a tax assessment in Brazil, along with the geographic mix of earnings. Generally, the provision for income taxes is primarily impacted by income earned in tax paying jurisdictions relative to income earned in non-tax paying jurisdictions. The majority of income recognized for purposes of computing the effective tax rate is earned in countries where the statutory income tax rates range from 15.0% to 35.6%; however, permanent income adjustments recorded against pre-tax earnings may result in an effective tax rate that is higher or lower than the statutory tax rate in these jurisdictions. The Company generates losses in certain jurisdictions for which no tax benefit is realized, as the deferred tax assets in these jurisdictions (including the net operating losses) are fully reserved in the valuation allowance. For this reason, the Company recognizes minimal income tax expense or benefit in these jurisdictions, of which the most material jurisdictions are the United States and Australia. Due to these reserves, the geographic mix of the Company’s pre-tax earnings has a direct correlation with how high or low its annual effective tax rate is relative to consolidated earnings.
As the Company continues to reorganize and restructure its operations, it is possible that deferred tax assets, for which no income tax benefit has previously been provided, may more likely than not become realized. During the quarter ended September 30, 2015, the Company reassessed its valuation allowance requirements related to its Australian operations, evaluating all available evidence in its analysis, both positive and negative, including historical and projected income and losses before the provision for income taxes, as well as reversals of temporary differences. The Company also considered tax planning strategies that are prudent and can be reasonably implemented if needed in order to realize the related tax benefits. During the third quarter of 2015, the Company recorded $1,809 of tax benefits related to the reversal of a portion of its valuation allowance previously established against its Australian net deferred tax assets. The Company believes that the deferred tax assets are more likely than not to be realized based on estimates of future taxable income generated by future earnings of the Australian business. The Company continues to evaluate future operations and will record an income tax benefit in the period where it believes it is more likely than not that the deferred tax asset will be able to be realized. Historic and future ownership changes could potentially reduce the amount of net operating loss carry-forwards available for use.
As of September 30, 2015, the Company had a gross amount of unrecognized tax benefit of $7,913, exclusive of interest and penalties. The unrecognized tax benefit increased by approximately $412 during the nine months ended September 30, 2015, as a result of ongoing changes in currently reserved positions as a result of new facts or information and the effects of income tax audits, which was partially offset by decreases related to foreign currency effects. In January 2015, the Company received notice of a tax audit report which could lead to an income tax assessment of an unknown amount related to its Italian operations. The Company expects to litigate if such an assessment is received, and the Company believes it would prevail on some portion of the issues litigated. As a result of this new information, the unrecognized tax benefit was increased by $1,269 for tax, interest and penalties related to this matter throughout 2015.
The Company’s policy is to recognize interest and penalties related to income tax matters as income tax expense, which were $(89) and $806 related to the unrecognized tax benefits for the three and nine months ended September 30, 2015. The tax years 2000 through 2014 remain open to examination in a number of the major tax jurisdictions to which the Company and its subsidiaries are subject. The Company believes that it has made adequate provisions for all income tax uncertainties.
5. Pensions, Other Post-retirement and Post-employment Benefits
The Company accounts for its pensions, other post-retirement and post-employment benefit plans in accordance with ASC Topic 715, Compensation—Retirement Benefits (“Topic 715”). The Company has defined benefit pension plans covering substantially all of its U.S. and Canadian employees and employees of certain subsidiaries in other countries. Benefits are generally based on the employee’s years of service and compensation. These plans are funded in conformity with the funding requirements of applicable government regulations. The Company does not fund certain plans, as funding is not required. The Company plans to continue to fund its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. In addition, the Company also intends to fund its U.K. and Canadian defined benefit plans in accordance with local regulations.

11


As required by Topic 715, the following tables summarize the components of net periodic benefit cost:
Defined Benefit Plans
Curtailment accounting was triggered with the announced closure of the Warwick facility. As a result, a curtailment gain was recorded in the third quarter of 2015 in the amount of $2.9 million, as a reduction to pension liability, and an increase to other comprehensive loss.
 
Three Months ended September 30,
 
Nine Months ended September 30,
 
2015
 
2014
 
2015
 
2014
Service cost
$
765

 
$
1,029

 
$
2,155

 
$
2,720

Interest cost
1,506

 
2,080

 
4,273

 
5,500

Expected return on plan assets
(1,638
)
 
(1,972
)
 
(4,645
)
 
(5,213
)
Amortization of net loss
676

 
371

 
1,932

 
981

Net periodic benefit cost
$
1,309

 
$
1,508

 
$
3,715

 
$
3,988

6. Comprehensive Loss and Accumulated Other Comprehensive Loss
Comprehensive loss for the three and nine months ended September 30, 2015 (net of tax expense of $97 and $183, respectively) and 2014 (net of tax benefit of $(268) and $235, respectively) is as follows:
 
 
Three Months ended September 30,
 
Nine Months ended September 30,
 
2015
 
2014
 
2015
 
2014
Net income (loss)
$
915

 
$
(20,472
)
 
$
1,945

 
$
(18,542
)
Foreign currency translation adjustments
(14,333
)
 
(21,902
)
 
(40,701
)
 
(22,216
)
Pension liability changes under Topic 715
2,320

 
1,338

 
4,797

 
1,190

Change in value of derivative instruments
86

 
33

 
253

 
86

Comprehensive loss
$
(11,012
)
 
$
(41,003
)
 
$
(33,706
)
 
$
(39,482
)
The components of accumulated other comprehensive loss for the three months ended September 30, 2015 are as follows (net of tax benefits of $7,970):
 
Foreign
Currency
Translation    
Adjustment
 
Pension
Liability
Changes Under 
Topic 715
 
Change in
Value of
Derivative
Instruments   
 
Accumulated   
Other
Comprehensive
(Loss) Income
Balance at June 30, 2015
$
(65,382
)
 
$
(44,339
)
 
$
59

 
$
(109,662
)
Other comprehensive loss before reclassifications
(14,333
)
 
(660
)
 

 
(14,993
)
Amounts reclassified from other comprehensive loss
 
 
 
 
 
 
 
    Amortization of actuarial losses

 
676

 

 
676

     Pension curtailment

 
2,304

 

 
2,304

    Amortization of interest expense

 

 
86

 
86

Net current period other comprehensive loss (income)
(14,333
)
 
2,320

 
86

 
(11,927
)
Balance at September 30, 2015
$
(79,715
)
 
$
(42,019
)
 
$
145

 
$
(121,589
)
 
 
 
 
 
 
 
 

12


The components of accumulated other comprehensive loss for the nine months ended September 30, 2015 are as follows (net of tax benefits of $7,970):
 
Foreign
Currency
Translation    
Adjustment
 
Pension
Liability
Changes Under 
Topic 715
 
Change in
Value of
Derivative
Instruments   
 
Accumulated   
Other
Comprehensive
(Loss) Income
Balance at December 31, 2014
$
(39,014
)
 
$
(46,816
)
 
$
(108
)
 
$
(85,938
)
Other comprehensive loss before reclassifications
(40,701
)
 
561

 

 
(40,140
)
Amounts reclassified from other comprehensive loss
 
 
 
 
 
 
 
    Amortization of actuarial losses

 
1,932

 

 
1,932

    Pension curtailment

 
2,304

 

 
2,304

    Amortization of interest expense

 

 
253

 
253

Net current period other comprehensive (loss) income
(40,701
)
 
4,797

 
253

 
(35,651
)
Balance at September 30, 2015
$
(79,715
)
 
$
(42,019
)
 
$
145

 
$
(121,589
)
 
 
 
 
 
 
 
 
For the three and nine months ended September 30, 2015, the amortization of actuarial losses is included in cost of products sold and general and administrative expenses in the Consolidated Statements of Operations.
For the nine months ended September 30, 2015, the impact on Accumulated Other Comprehensive Loss ("AOCL") due to foreign currency translation adjustments of $(40,701) was primarily the result of the decline in the Euro and Brazilian Real and the effect of that decline on our foreign subsidiaries net equity balances of $151 million (Euro) and $107 million (Brazilian Real) in Europe and Brazil, respectively. The Euro declined to $1.12 at September 30, 2015 from $1.22 at December 31, 2014. The Brazilian Real declined to $0.25 at September 30, 2015 from $0.37 at December 31, 2014.

7. Restructuring and Impairment Expense
In October of 2015, the Company announced the permanent consolidation of its rolls manufacturing facility in Middletown, Virginia into other rolls manufacturing facilities. This closure will not affect the operations of the Company's global rolls R&D center in Middletown. It will give the R&D team more room to accomplish product development and prototypes on next generation products. The time-line to complete this process is by the end of March of 2016. The Company accrued $0.7 million in severance and asset relocation related charges in October of 2015 as a result of this consolidation.
       
In June of 2015, the Company announced that it had initiated closure proceedings with the representative union officials at our machine clothing facility in Warwick, Quebec, Canada in order to continue to address our cost structure. In the second and third quarters of 2015, the Company incurred $3.5 million in employee-related and other restructuring expenses. In addition, we recognized $1.0 million in impairment charges related to the building during the third quarter of 2015 related to this closure. The building is classified as held for sale in the Company's Consolidated Condensed Balance Sheet at September 30, 2015 and currently has a carrying value of $0.5 million. The Company determined that this value falls within level 2 of the fair value hierarchy, based on sale price of comparable properties.

For the nine months ended September 30, 2015, the Company incurred restructuring expenses of $12.7 million. These included $4.1 million of charges related to the closure of the Joao Pessoa, Brazil clothing facility, $4.5 million charges related to the closure of Warwick, Canada machine clothing facility, as described above, and $4.1 million of charges relating to headcount reductions and other costs related to previous plant closures. For the nine months ended September 30, 2014, the Company incurred restructuring expenses of $15.7 million. These included charges relating to headcount reductions of $4.2 million, $3.0 million relating to the closure of the Joao Pessoa, Brazil plant, $1.6 million relating to the termination of a sales agency contract in Italy, $2.2 million relating to the closures of machine clothing facilities in Argentina and Spain, $3.7 million relating to the closure of the Heidenheim facility, $0.7 million relating to the transfer of certain machinery and equipment from the closed France rolls facility to a China based rolls facility and other locations in Europe, and $0.3 million relating to the liquidation of the Vietnam facility.

13


The following table sets forth the significant components of the restructuring accrual (included in Accrued Expenses on our Consolidated Balance Sheet), including activity under restructuring programs for the nine months ended September 30, 2015 and 2014:
  
 
Balance at
December 31, 
2014
 
Charges (1)
 
Currency    
Effects
 
Cash
Payments    
 
Balance at
September 30, 2015
Severance and other benefits
$
4,880

 
$
6,007

 
$
(469
)
 
$
(4,744
)
 
$
5,674

Facility costs and other
818

 
5,741

 
(76
)
 
(5,588
)
 
895

Total
$
5,698

 
$
11,748

 
$
(545
)
 
$
(10,332
)
 
$
6,569


(1) Excludes $986 of impairment expense.
 
 
Balance at
December 31, 
2013
 
Charges (1)
 
Currency    
Effects
 
Cash
Payments    
 
Balance at
September 30, 2014
Severance and other benefits
$
6,466

 
$
11,737

 
$
(559
)
 
$
(11,884
)
 
$
5,760

Facility costs and other
1,468

 
3,698

 
(176
)
 
(2,963
)
 
2,027

Total
$
7,934

 
$
15,435

 
$
(735
)
 
$
(14,847
)
 
$
7,787

(1) Excludes $277 of impairment expense.
Restructuring and impairment expense by segment, which is not included in Segment Earnings in Note 8, is as follows:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2015
 
2014
 
2015
 
2014
Clothing
$
4,414

 
$
2,168

 
$
11,516

 
$
10,273

Roll Covers
540

 
1,272

 
827

 
5,310

Corporate
47

 
26

 
391

 
129

Total
$
5,001

 
$
3,466

 
$
12,734

 
$
15,712

8. Business Segment Information
The Company is a global manufacturer and supplier of consumable products used primarily in the production of paper and is organized into two reportable segments: clothing and roll covers. The clothing segment represents the manufacture and sale of synthetic textile belts used to transport paper along the length of papermaking machines. The roll covers segment primarily represents the manufacture and refurbishment of covers used on the steel rolls of papermaking machines and the servicing of those rolls. The Company manages each of these operating segments separately.
Management evaluates segment performance based on earnings before interest, taxes, depreciation and amortization, yet after allocation of corporate charges. Such measure is then adjusted to exclude items that are of an unusual nature and are not used in measuring segment performance or are not segment specific (“Segment Earnings (Loss)”). The accounting policies of these segments are the same as those for the Company as a whole. Inter-segment net sales and inter-segment eliminations are not material for any of the periods presented.
Summarized financial information for the Company’s reportable segments is presented in the tables that follow for the three and nine months ended September 30, 2015 and 2014.

14


 
Clothing       
 
Roll
Covers        
 
Corporate     
 
Total
Three Months Ended September 30, 2015:
 
 
 
 
 
 
 
Net Sales
$
72,536

 
$
45,203

 
$

 
$
117,739

Segment Earnings (Loss)
$
22,230

 
$
9,685

 
$
(3,654
)
 

Three Months Ended September 30, 2014:
 
 
 
 
 
 
 
Net Sales
$
86,085

 
$
52,773

 
$

 
$
138,858

Segment Earnings (Loss)
$
23,254

 
12,290

 
(4,080
)
 


 
 
 
 
 
 
 
 
Nine Months ended September 30, 2015:
 
 
 
 
 
 
 
Net Sales
$
228,971

 
$
132,925

 
$

 
$
361,896

Segment Earnings (Loss)
$
66,076

 
26,864

 
(10,467
)
 
 
Nine Months ended September 30, 2014:
 
 
 
 
 
 
 
Net Sales
$
264,561

 
$
147,404

 
$

 
$
411,965

Segment Earnings (Loss)
$
66,834

 
30,352

 
(10,600
)
 
 
Provided below is a reconciliation of Segment Earnings (Loss) to income before provision for income taxes for the three and nine months ended September 30, 2015 and 2014, respectively.
 
Three Months ended September 30,
 
Nine Months ended September 30,
 
2015
 
2014
 
2015
 
2014
Segment Earnings (Loss):
 
 
 
 
 
 
 
Clothing
$
22,230

 
$
23,254

 
$
66,076

 
$
66,834

Roll Covers
9,685

 
12,290

 
26,864

 
30,352

Corporate
(3,654
)
 
(4,080
)
 
(10,467
)
 
(10,600
)
Stock-based compensation
(1,064
)
 
(709
)
 
(2,690
)
 
(1,858
)
Inventory write-off related to closed facilities
(465
)
 

 
(465
)
 

Idle equipment asset impairment
(149
)
 

 
(149
)
 

Interest expense, net
(9,775
)
 
(9,412
)
 
(28,144
)
 
(26,985
)
Depreciation and amortization
(7,207
)
 
(8,594
)
 
(21,625
)
 
(26,180
)
Restructuring expense
(5,001
)
 
(3,466
)
 
(12,734
)
 
(15,712
)
Non-recurring expense
(1,552
)
 

 
(2,402
)
 

Plant startup costs
(1,378
)
 
(537
)
 
(3,110
)
 
(953
)
Income before provision for income taxes
$
1,670

 
$
8,746

 
$
11,154

 
$
14,898


9. Commitments and Contingencies
The Company is involved in various legal matters which have arisen in the ordinary course of business as a result of various immaterial labor claims, taxing authority reviews and other routine legal matters. As of September 30, 2015, the Company accrued an immaterial amount in its financial statements for these matters for which the Company believed the possibility of loss was probable and was able to estimate the damages. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its financial position, results of operations or cash flow. The Company believes that any additional liability in excess of amounts provided which may result from the resolution of legal matters will not have a material adverse effect on the financial condition, liquidity or cash flow of the Company.

10. Stock-Based Compensation and Stockholders’ Deficit
The Company records stock-based compensation expense in accordance with ASC Topic 718, Accounting for Stock Compensation and has used the straight-line attribution method to recognize expense for RSUs, options and DSUs. The Company recorded stock-based compensation expense during the three and nine months ended September 30, 2015 and September 30, 2014 as follows: 

15


 
 
Three Months ended September 30,
 
Nine Months ended September 30,
 
 
2015
 
2014
 
2015
 
2014
RSU, Options and DSU Awards (1)
 
$
1,064

 
$
709

 
$
2,690

 
$
1,858

 
(1)
Related to RSUs, Options and DSUs awarded to certain employees and non-employee directors.
 
Summary of Activity under the Long-Term Incentive Plans

On March 2, 2015, the Board of Directors approved the 2015-2017 Long-Term Incentive Plan (the “2015 - 2017 LTIP”) under the 2010 Equity Incentive Plan (the “2010 Plan”). Awards under the 2015 - 2017 LTIP are time-based, performance-based and market-based. A specific target share award has been set for each participant in the 2015-2017 LTIP. Awards will be paid in the form of shares of common stock of the Company, as described below:

52,601 Time-based awards, or 35% of the total target award for each participant, have been granted in the form of time-based restricted stock units under the Company’s 2010 Plan. The time-based restricted stock units vest on the third anniversary of the date of grant.
97,681 Performance-based and Market-based awards, 65% of the total target award for each participant, have been granted in the form of performance-based stock units under the 2010 Plan. Of these units, half will vest based on the financial performance of the Company and the other half will vest based on the stock price performance of the Company.

The performance-based stock units whose vesting is subject to the financial performance of the Company (the “financial stock units”) will vest based on the degree to which the Company achieves a targeted three-year cumulative Adjusted EBITDA metric, adjusted for currency fluctuations, over the performance period of January 1, 2015 through December 31, 2017. Financial stock units that vest will convert into shares of the Company’s common stock and be paid after the close of a three-year performance period. The amount of units that vest will range from 0% to 100% of the employee's total financial stock units. Upon attainment of cumulative Adjusted EBITDA equal to 80% or less of the targeted Adjusted EBITDA, none of the financial stock units will vest. Upon attainment of more than 80% of the targeted Adjusted EBITDA, the financial stock units will begin vesting on a straight-line basis from 0% of the financial stock units at 80% of the targeted Adjusted EBITDA to 100% of the financial stock units at 100% of the targeted Adjusted EBITDA, up to a maximum payout of 100% of the financial stock units.

The market-based stock units whose vesting is subject to stock price performance of the Company (the “market-based stock units”) will vest based on the Company's total stock price change (plus dividends) over the three-year performance period of March 2, 2015 through March 2, 2018 (“TSR”) relative to the TSR over the same performance period of companies listed on the S&P Global Small Cap Index on the third anniversary of the grant date, or March 2, 2018. Market-based stock units that vest will convert into shares of the Company’s common stock and will be paid after the third anniversary of the grant date, or March 2, 2018. The amount of units that vest will range from 0% to 100% of the employee's total market-based stock units. If the Company’s TSR over the performance period is less than the 35th percentile TSR of companies in the S&P Global Small Cap Index, then no market-based units will vest. If the Company’s TSR over the performance period is equal to the 35th percentile TSR of the companies in the S&P Global Small Cap Index, then 50% of the market-based stock units will vest. Full payout at 100% of the market-based stock units will be made if the Company’s TSR over the performance period is equal to the 55th percentile TSR of companies in the S&P Global Small Cap Index. TSR performance between the 35th and 55th percentile TSR of companies in the S&P Global Small Cap Index will result in an interpolated payout percentage of the market-based stock units between 50% and 100%.

Subject to early acceleration and payment under certain circumstances consistent with the terms of the Company’s 2015-2017 LTIP and LTIP Share Agreement thereunder, delivery of shares of common stock underlying the time-based and performance-based and market-based awards that become vested are subject to the participant’s continued service to the Company through March 2, 2018.

Other Stock Compensation Plans
On August 15, 2012, the Company granted Harold Bevis, the Company's CEO, an award of 204,208 restricted stock units and options to acquire 781,701 shares of the Company's common stock, par value $0.001 per share. Both the restricted stock

16


units and the options vest over a three year period, with the first and second tranches having vested on August 15, 2014 and 2015. The options have a 10-year term and an exercise price of $4.00 per share, the August 15, 2012 closing price of the Company's common stock on the New York Stock Exchange. On August 15, 2015, one third of Mr. Bevis's restricted stock units and options vested. Mr. Bevis received 35,596 shares of common stock, net of withholdings as a result of the restricted stock unit vesting. In addition, Mr. Bevis exercised his vested options, and received 99,632 shares of common stock, in a cashless exercise, net of withholdings.
Directors’ Deferred Stock Unit Plan
Under the 2011 non-management directors stock plan ("2011 DSU Plan”), as amended in January of 2015, each director receives an annual retainer of $132, to be paid on a quarterly basis in arrears. Approximately half of the annual retainer is payable in DSUs, with the remaining half payable in DSUs, cash or a mix of both at the election of each director. The non-management directors were awarded an aggregate of 8,539 DSUs under the 2011 DSU Plan for service during the quarter ended September 30, 2015. In addition, in accordance with the 2011 DSU Plan, as amended in January of 2015, 6,077 DSUs were settled in common stock during the quarter ended September 30, 2015.

11. Supplemental Guarantor Financial Information
On May 26, 2011, the Company closed on the sale of its Notes. The Notes are unsecured obligations of the Company and are fully and unconditionally guaranteed on a senior unsecured basis by all of the domestic wholly owned subsidiaries of the Company (the “Guarantors”). In accordance with Rule 3-10 of Regulation S-X promulgated under the Securities Act of 1933, as amended, the following condensed consolidating financial statements present the financial position, results of operations and cash flows of Xerium Technologies, Inc. (referred to as “Parent” for the purpose of this note only) on a stand-alone parent-only basis, the Guarantors on a Guarantors-only basis, the combined non-Guarantor subsidiaries and elimination entries necessary to arrive at the information for the Parent, the Guarantors and non-Guarantor subsidiaries on a consolidated basis.

17


Xerium Technologies, Inc.
Consolidating Balance Sheet—(Unaudited)
At September 30, 2015
(Dollars in thousands)
 
 
Parent
 
Total
Guarantors
 
Total Non
Guarantors
 
Other
Eliminations
 
The
Company
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
3,710

 
$
(4
)
 
$
6,998

 
$

 
$
10,704

Accounts receivable, net
120

 
22,492

 
55,201

 

 
77,813

Intercompany receivables
(94,067
)
 
114,766

 
(20,699
)
 

 

Inventories, net

 
16,235

 
56,493

 
(925
)
 
71,803

Prepaid expenses
1,246

 
1,564

 
5,465

 

 
8,275

Other current assets

 
2,273

 
13,845

 

 
16,118

Total current assets
(88,991
)
 
157,326

 
117,303

 
(925
)
 
184,713

Property and equipment, net
8,985

 
63,517

 
224,068

 

 
296,570

Investments
815,977

 
212,844

 

 
(1,028,821
)
 

Goodwill

 
17,737

 
43,439

 

 
61,176

Intangible assets
6,877

 
1,457

 
792

 

 
9,126

Non-current deferred tax asset

 

 
9,555

 

 
9,555

Other assets

 
364

 
8,734

 

 
9,098

Total assets
$
742,848

 
$
453,245

 
$
403,891

 
$
(1,029,746
)
 
$
570,238

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$
3,546

 
$
10,732

 
$
23,694

 
$

 
$
37,972

Accrued expenses
12,154

 
9,557

 
36,283

 

 
57,994

Notes payable

 

 
6,742

 

 
6,742

Current maturities of long-term debt
7,333

 
733

 
2,821

 

 
10,887

Total current liabilities
23,033

 
21,022

 
69,540

 

 
113,595

Long-term debt, net of current maturities
459,191

 

 
7,496

 

 
466,687

Liabilities under capital leases
3,337

 
761

 
969

 

 
5,067

Non-current deferred tax liability
758

 
1,035

 
6,098

 

 
7,891

Pension, other post-retirement and post-employment obligations
20,679

 
2,223

 
48,248

 

 
71,150

Other long-term liabilities

 

 
13,099

 

 
13,099

Intercompany loans
324,429

 
(399,025
)
 
74,596

 

 

Total stockholders’ (deficit) equity
(88,579
)
 
827,229

 
183,845

 
(1,029,746
)
 
(107,251
)
Total liabilities and stockholders’ equity
$
742,848

 
$
453,245

 
$
403,891

 
$
(1,029,746
)
 
$
570,238


18


Xerium Technologies, Inc.
Consolidating Balance Sheet
At December 31, 2014
(Dollars in thousands)
 
 
Parent        
 
Total
Guarantors    
 
Total Non
Guarantors    
 
Other
Eliminations
 
The
Company      
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
605

 
$
(14
)
 
$
8,926

 
$

 
$
9,517

Accounts receivable, net
50

 
22,358

 
60,661

 

 
83,069

Intercompany receivables
(107,064
)
 
107,589

 
(525
)
 

 

Inventories, net

 
17,310

 
67,016

 
(776
)
 
83,550

Prepaid expenses
546

 
1,470

 
6,456

 

 
8,472

Other current assets

 
2,021

 
13,693

 

 
15,714

Total current assets
(105,863
)
 
150,734

 
156,227

 
(776
)
 
200,322

Property and equipment, net
12,365

 
59,448

 
231,804

 

 
303,617

Investments
782,633

 
229,109

 

 
(1,011,742
)
 

Goodwill

 
17,737

 
44,190

 

 
61,927

Intangible assets
9,001

 
1,664

 
1,042

 

 
11,707

Non-current deferred tax asset

 

 
10,662

 
 
 
10,662

Other assets

 
364

 
5,445

 

 
5,809

Total assets
$
698,136

 
$
459,056

 
$
449,370

 
$
(1,012,518
)
 
$
594,044

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$
2,679

 
$
10,212

 
$
28,936

 
$

 
$
41,827

Accrued expenses
8,511

 
8,301

 
39,297

 

 
56,109

Notes payable

 

 
244

 

 
244

Current maturities of long-term debt
2,944

 

 
1,462

 

 
4,406

Total current liabilities
14,134

 
18,513

 
69,939

 

 
102,586

Long-term debt, net of current maturities
460,840

 

 

 

 
460,840

Liabilities under capital leases
3,503

 
440

 
2

 

 
3,945

Non-current deferred tax liability
97

 
1,035

 
9,284

 

 
10,416

Pension, other post-retirement and post-employment obligations
22,070

 
1,200

 
57,201

 

 
80,471

Other long-term liabilities
181

 

 
9,715

 

 
9,896

Intercompany loans
289,896

 
(401,482
)
 
111,586

 

 

Total stockholders’ (deficit) equity
(92,585
)
 
839,350

 
191,643

 
(1,012,518
)
 
(74,110
)
Total liabilities and stockholders’ (deficit) equity
$
698,136

 
$
459,056

 
$
449,370

 
$
(1,012,518
)
 
$
594,044


19


Xerium Technologies, Inc.
Consolidating Statement of Operations and Comprehensive Income (Loss) (Unaudited)
For the three months ended September 30, 2015
(Dollars in thousands)
 
 
Parent    
 
Total
Guarantors
 
Total  Non
Guarantors
 
Other
Eliminations
 
The
Company
Net sales
$

 
$
41,978

 
$
80,090

 
$
(4,329
)
 
$
117,739

Costs and expenses:
 
 
 
 
 
 
 
 
 
    Cost of products sold
38

 
28,157

 
47,439

 
(4,382
)
 
71,252

    Selling
248

 
4,940

 
10,701

 

 
15,889

    General and administrative
4,403

 
1,658

 
8,309

 

 
14,370

    Research and development
259

 
1,118

 
464

 

 
1,841

    Restructuring
47

 
307

 
4,647

 

 
5,001

 
4,995

 
36,180

 
71,560

 
(4,382
)
 
108,353

(Loss) income from operations
(4,995
)
 
5,798

 
8,530

 
53

 
9,386

Interest (expense) income, net
(9,613
)
 
877

 
(1,039
)
 

 
(9,775
)
Foreign exchange gain (loss)
404

 
(26
)
 
1,681

 

 
2,059

Equity in subsidiaries income
10,415

 
9,460

 

 
(19,875
)
 

Dividend income
4,769

 

 

 
(4,769
)
 

Income before provision for income taxes
980

 
16,109

 
9,172

 
(24,591
)
 
1,670

Provision for income taxes
(65
)
 
(19
)
 
(671
)
 

 
(755
)
Net income
$
915

 
$
16,090

 
$
8,501

 
$
(24,591
)
 
$
915

Comprehensive income (loss)
$
1,084

 
$
16,391

 
$
(3,896
)
 
$
(24,591
)
 
$
(11,012
)

Xerium Technologies, Inc.
Consolidating Statement of Operations and Comprehensive Income-(Unaudited)
For the three months ended September 30, 2014
(Dollars in thousands)
 
 
Parent    
 
Total
Guarantors
 
Total  Non
Guarantors
 
Other
Eliminations
 
The
Company
Net sales
$

 
$
48,514

 
$
98,675

 
$
(8,331
)
 
$
138,858

Costs and expenses:
 
 
 
 
 
 
 
 
 
    Cost of products sold
(225
)
 
32,320

 
59,726

 
(8,457
)
 
83,364

    Selling
394

 
5,264

 
12,537

 

 
18,195

    General and administrative
2,615

 
1,497

 
10,021

 

 
14,133

    Research and development
244

 
1,189

 
476

 

 
1,909

    Restructuring
26

 
123

 
3,317

 

 
3,466

 
3,054

 
40,393

 
86,077

 
(8,457
)
 
121,067

(Loss) income from operations
(3,054
)
 
8,121

 
12,598

 
126

 
17,791

Interest (expense) income, net
(8,842
)
 
1,367

 
(1,937
)
 

 
(9,412
)
Foreign exchange (loss) gain
(346
)
 
(60
)
 
773

 

 
367

Equity in subsidiaries (loss) income
(7,787
)
 
(18,580
)
 

 
26,367

 

(Loss) income before provision for income taxes
(20,029
)
 
(9,152
)
 
11,434

 
26,493

 
8,746

Provision for income taxes
(443
)
 
(22
)
 
(28,753
)
 

 
(29,218
)
Net loss
$
(20,472
)
 
$
(9,174
)
 
$
(17,319
)
 
$
26,493

 
$
(20,472
)
Comprehensive loss
$
(21,626
)
 
$
(9,251
)
 
$
(36,619
)
 
$
26,493

 
$
(41,003
)




20


Xerium Technologies, Inc.
Consolidating Statement of Operations and Comprehensive Income (Loss) (Unaudited)
For the nine months ended September 30, 2015
(Dollars in thousands)
 
Parent    
 
Total
Guarantors
 
Total  Non
Guarantors
 
Other
Eliminations
 
The
Company
Net sales
$

 
$
126,416

 
$
251,958

 
$
(16,478
)
 
$
361,896

Costs and expenses:
 
 
 
 
 
 
 
 
 
    Cost of products sold
(291
)
 
85,079

 
148,954

 
(16,329
)
 
217,413

    Selling
787

 
14,790

 
33,068

 

 
48,645

    General and administrative
9,285

 
4,539

 
26,437

 

 
40,261

    Research and development
732

 
3,508

 
1,455

 

 
5,695

    Restructuring
8,313

 
622

 
3,799

 

 
12,734

 
18,826

 
108,538

 
213,713

 
(16,329
)
 
324,748

(Loss) income from operations
(18,826
)
 
17,878

 
38,245

 
(149
)
 
37,148

Interest (expense) income, net
(28,303
)
 
3,009

 
(2,850
)
 

 
(28,144
)
Foreign exchange gain (loss)
246

 
(261
)
 
2,165

 

 
2,150

Equity in subsidiaries income
38,843

 
21,009

 

 
(59,852
)
 

Dividend income
10,856

 

 

 
(10,856
)
 

Income before provision for income taxes
2,816

 
41,635

 
37,560

 
(70,857
)
 
11,154

Provision for income taxes
(871
)
 
(89
)
 
(8,249
)
 

 
(9,209
)
Net income
$
1,945

 
$
41,546

 
$
29,311

 
$
(70,857
)
 
$
1,945

Comprehensive income (loss)
$
3,439

 
$
42,462

 
$
(8,750
)
 
$
(70,857
)
 
$
(33,706
)

Xerium Technologies, Inc.
Consolidating Statement of Operations and Comprehensive Income-(Unaudited)
For the nine months ended September 30, 2014
(Dollars in thousands)
 
 
Parent    
 
Total
Guarantors
 
Total  Non
Guarantors
 
Other
Eliminations
 
The
Company
Net sales
$

 
$
139,352

 
$
299,501

 
$
(26,888
)
 
$
411,965

Costs and expenses:
 
 
 
 
 
 
 
 
 
    Cost of products sold
(1,095
)
 
95,050

 
182,029

 
(27,030
)
 
248,954

    Selling
700

 
15,530

 
39,132

 

 
55,362

    General and administrative
6,764

 
5,966

 
30,607

 

 
43,337

    Research and development
779

 
3,453

 
1,667

 

 
5,899

    Restructuring
129

 
868

 
14,715

 

 
15,712

 
7,277

 
120,867

 
268,150

 
(27,030
)
 
369,264

(Loss) income from operations
(7,277
)
 
18,485

 
31,351

 
142

 
42,701

Interest (expense) income, net
(25,546
)
 
4,132

 
(5,571
)
 

 
(26,985
)
Foreign exchange loss
(549
)
 
(115
)
 
(154
)
 

 
(818
)
Equity in subsidiaries income (loss)
15,558

 
(8,897
)
 

 
(6,661
)
 

(Loss) income before provision for income taxes
(17,814
)
 
13,605

 
25,626

 
(6,519
)
 
14,898

Provision for income taxes
(728
)
 
(100
)
 
(32,612
)
 

 
(33,440
)
Net (loss) income
$
(18,542
)
 
$
13,505

 
$
(6,986
)
 
$
(6,519
)
 
$
(18,542
)
Comprehensive (loss) income
$
(19,138
)
 
$
13,087

 
$
(26,912
)
 
$
(6,519
)
 
$
(39,482
)




21


Xerium Technologies, Inc.
Consolidating Statement of Cash Flows-(Unaudited)
For the nine months ended September 30, 2015
(Dollars in thousands)
 
Parent    
 
Total
Guarantors
 
Total Non
Guarantors
 
Other
Eliminations
 
The
 Company 
Operating activities
 
 
 
 
 
 
 
 
 
Net income
$
1,945

 
$
41,546

 
$
29,311

 
$
(70,857
)
 
$
1,945

Adjustments to reconcile net income to net cash (used in) provided by operating activities:
 
 
 
 
 
 
 
 
 
Stock-based compensation
2,506

 

 
184

 

 
2,690

Depreciation
1,110

 
5,292

 
14,995

 

 
21,397

Amortization of intangibles

 
206

 
22

 

 
228

Deferred financing cost amortization
2,570

 

 
71

 

 
2,641

Foreign exchange gain on revaluation of debt
(2,115
)
 

 

 

 
(2,115
)
Deferred taxes
661

 

 
(2,232
)
 

 
(1,571
)
Asset impairment

 
149

 
1,029

 

 
1,178

Loss (gain) on disposition of property and equipment
4

 
27

 
(116
)
 

 
(85
)
Provision for doubtful accounts

 
276

 
581

 

 
857

Undistributed equity in earnings of subsidiaries
(38,843
)
 
(21,009
)
 

 
59,852

 

Change in assets and liabilities which provided (used) cash:
 
 
 
 
 
 
 
 


Accounts receivable
(70
)
 
(409
)
 
(2,310
)
 

 
(2,789
)
Inventories

 
1,074

 
2,417

 
149

 
3,640

Prepaid expenses
(700
)
 
(94
)
 
77

 

 
(717
)
Other current assets

 
(252
)
 
(1,773
)
 

 
(2,025
)
Accounts payable and accrued expenses
2,298

 
1,774

 
1,061

 

 
5,133

Deferred and other long-term liabilities
(238
)
 
1,023

 
(6,336
)
 

 
(5,551
)
Intercompany loans
(12,996
)
 
(7,108
)
 
20,104

 

 

Net cash (used in) provided by operating activities
(43,868
)
 
22,495

 
57,085

 
(10,856
)
 
24,856

Investing activities
 
 
 
 
 
 
 
 
 
Capital expenditures
(6,276
)
 
(7,862
)
 
(26,238
)
 

 
(40,376
)
Intercompany property and equipment transfers, net
8,612

 
(220
)
 
(8,392
)
 

 

Proceeds from disposals of property and equipment
3

 
26

 
75

 

 
104

Net cash provided by (used in) investing activities
2,339

 
(8,056
)
 
(34,555
)
 

 
(40,272
)
Financing activities
 
 
 
 
 
 
 
 

Net increase in notes payable

 

 
6,759

 
 
 
6,759

Proceeds from borrowings
37,408

 

 
20,020

 

 
57,428

Principal payments on debt
(34,371
)
 

 
(11,202
)
 

 
(45,573
)
Dividends paid

 
(9,950
)
 
(906
)
 
10,856

 

Payment of obligations under capital leases
(486
)
 
(401
)
 

 

 
(887
)
Payment of financing fees
(63
)
 

 
45

 

 
(18
)
Intercompany loans
36,646

 
(4,078
)
 
(32,568
)
 

 

Other financing activities
5,500

 
 
 
(5,500
)
 
 
 

Net cash provided by (used in) financing activities
44,634

 
(14,429
)
 
(23,352
)
 
10,856

 
17,709

Effect of exchange rate changes on cash flows

 

 
(1,106
)
 

 
(1,106
)
Net increase (decrease) in cash
3,105

 
10

 
(1,928
)
 

 
1,187

Cash and cash equivalents at beginning of period
605

 
(14
)
 
8,926

 

 
9,517

Cash and cash equivalents at end of period
$
3,710

 
$
(4
)
 
$
6,998

 
$

 
$
10,704


22



Xerium Technologies, Inc.
Consolidating Statement of Cash Flows (Unaudited)
For the nine months ended September 30, 2014
(Dollars in Thousands)
 
Parent    
 
Total
Guarantors
 
Total Non
Guarantors
 
Other
Eliminations
 
The
 Company 
Operating activities
 
 
 
 
 
 
 
 
 
Net (loss) income
$
(18,542
)
 
$
13,505

 
$
(6,986
)
 
$
(6,519
)
 
$
(18,542
)
Adjustments to reconcile net (loss)income to net cash (used in) provided by operating activities:
 
 
 
 
 
 
 
 
 
Stock-based compensation
1,673

 

 
185

 

 
1,858

Depreciation
809

 
5,415

 
18,726

 

 
24,950

Amortization of intangibles

 
1,151

 
79

 

 
1,230

Deferred financing cost amortization
2,394

 

 
15

 

 
2,409

Foreign exchange gain on revaluation of debt
(340
)
 

 

 

 
(340
)
Deferred taxes
656

 

 
853

 

 
1,509

Asset impairment

 

 
277

 

 
277

Loss (gain) on disposition of property and equipment

 
27

 
(31
)
 

 
(4
)
Provision for doubtful accounts

 
166

 
118

 

 
284

Undistributed equity in earnings of subsidiaries
(15,558
)
 
8,897

 

 
6,661

 

Change in assets and liabilities which provided (used) cash:
 
 
 
 
 
 
 
 


Accounts receivable
(10
)
 
(705
)
 
(4,332
)
 

 
(5,047
)
Inventories

 
600

 
(8,355
)
 
(142
)
 
(7,897
)
Prepaid expenses
365

 
(802
)
 
557

 

 
120

Other current assets
514

 
(517
)
 
1,226

 

 
1,223

Accounts payable and accrued expenses
2,894

 
485

 
208

 

 
3,587

Deferred and other long-term liabilities
(585
)
 
(39
)
 
(3,676
)
 

 
(4,300
)
Intercompany loans
(18,899
)
 
553

 
18,346

 

 

Net cash (used in) provided by operating activities
(44,629
)
 
28,736

 
17,210

 

 
1,317

Investing activities
 
 
 
 
 
 
 
 
 
Capital expenditures
(10,229
)
 
(4,089
)
 
(19,348
)
 

 
(33,666
)
Intercompany property and equipment transfers, net
13,204

 
(6
)
 
(13,198
)
 

 

Proceeds from disposals of property and equipment

 
36

 
127

 

 
163

Other Investing Activities
(26,100
)
 
25,600

 
500

 

 

Net cash (used in) provided by investing activities
(23,125
)
 
21,541

 
(31,919
)
 

 
(33,503
)
Financing activities
 
 
 
 
 
 
 
 

Proceeds from borrowings
67,943

 

 
5,636

 

 
73,579

Principal payments on debt
(39,449
)
 

 
(5,385
)
 

 
(44,834
)
Payments of obligations under capitalized leases
(383
)
 
(251
)
 

 

 
(634
)
Payment of deferred financing fees
(623
)
 

 
(775
)
 

 
(1,398
)
Intercompany loans
37,885

 
(50,026
)
 
12,141

 

 

Net cash provided by provided by (used in) financing activities
65,373

 
(50,277
)
 
11,617

 

 
26,713

Effect of exchange rate changes on cash flows

 
1

 
(431
)
 

 
(430
)
Net (decrease) increase in cash
(2,381
)
 
1

 
(3,523
)
 

 
(5,903
)
Cash and cash equivalents at beginning of period
4,120

 
(10
)
 
21,606

 

 
25,716

Cash and cash equivalents at end of period
$
1,739

 
$
(9
)
 
$
18,083

 
$

 
$
19,813



23


ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to the safe harbor created by that Act. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. In some cases, forward-looking statements can be identified by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” or “continue” or the negative of these terms or other comparable terminology. Undue reliance should not be placed on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors that are, in some cases, beyond our control and that could materially affect actual results, levels of activity, performance, or achievements. Factors that could materially affect our actual results, levels of activity, performance or achievements include the following items:

our strategy to lower our costs in response to market changes in the paper industry;
               
execution risk related to the startup of our proposed new facilities in China and Turkey and our expansion projects;
               
local economic conditions in the areas around the world where we conduct business;
               
structural shifts in the demand for paper;
               
the effectiveness of our strategies and plans;
               
fluctuations in interest rates and currency exchange rates;
              
sudden increase or decrease in production capacity;
               
our development and marketing of new technologies and our ability to compete against new technologies developed by competitors;
               
variations in demand for our products, including our new products;
               
fluctuations in the price of our component supply costs and energy costs;
               
our ability to generate substantial operating cash flow to fund growth and unexpected cash needs;
               
occurrences of terrorist attacks or an armed conflict involving the United States or any other country in which we conduct business, or any other domestic or international calamity, including natural disasters;
               
 changes in the policies, laws, regulations and practices of the United States and any foreign country in which we operate or conduct business, including changes regarding taxes and the repatriation of earnings; and
               
 anti-takeover provisions in our charter documents.

Other factors that could materially affect our actual results, levels of activity, performance or achievements can be found in our “Risk Factors” section in our Annual Report on Form 10-K for the year ended December 31, 2014, filed with the SEC on March 4, 2015. If any of these risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary significantly from what we project. Any forward-looking statement in this Quarterly Report on Form 10-Q reflects our current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to our operations, results of operations, growth strategy, and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, whether as a result of new information, future events, or otherwise, except as required by law.
All references in this Quarterly Report to “Xerium”, “the Company”, “we”, “our” and “us” means Xerium Technologies, Inc. and its subsidiaries.


24


Company Overview
We are a leading global manufacturer and supplier of two types of consumable products used primarily in the production of paper—clothing and roll covers. Our operations are strategically located in the major paper-producing regions of North America, Europe, South America and Asia-Pacific. Our products play key roles in the formation and processing of paper along the length of a paper-making machine. Paper producers rely on our products and services to help improve the quality of their paper, differentiate their paper products, operate their paper-making machines more efficiently and reduce production costs.
We operate in two principal business segments: clothing and roll covers. In our clothing segment, we manufacture and sell highly engineered synthetic textile belts that transport paper as it is processed in a paper-making machine. Clothing plays a significant role in the forming, pressing and drying stages of paper production. Because paper-making processes and machine specifications vary widely, the clothing size, form, material and function is custom engineered to fit each individual paper-making machine and process. For the nine months ended September 30, 2015, our clothing segment represented 63% of our net sales.
Our roll cover products provide a surface with the mechanical properties necessary to process the paper sheet in a cost-effective manner that delivers the sheet qualities desired by each paper producer. We tailor our roll covers to individual paper-making machines and processes, using different materials, treatments and finishings. In addition to manufacturing and selling new roll covers, we also provide refurbishment services for previously installed roll covers and we manufacture new and rebuilt spreader rolls. We also provide various related products and services to our customers, both directly and through third party providers, as a growing part of our overall product offering through our roll covers sales channels. For the nine months ended September 30, 2015, our roll cover segment represented 37% of our net sales.
Industry Trends and Outlook

Demand for our products is driven primarily by the amount of machine hours consumed in the production of paper, pulp, tissue, nonwoven fabrics, and fiber cement products. These products are manufactured on a worldwide basis on specialized machines. Our products are consumed as a normal part of those manufacturing processes, and therefore the market available for the company’s products is in turn linked to the production of those final products. The end demand for paper, pulp, tissue, nonwoven fabrics, and fiber cement products follow their own business models. Certain types of products are growing, certain types are relatively stable, and certain types are declining.

When there is over-capacity for certain types of products relative to available demand, the industry usually reacts by curtailing or closing production. When there is a growing need for more capacity of certain types of products, the industry usually reacts by expanding capacity. In concert with these expansion and contractions, the company attempts to align its own production capacity.

There are certain macro themes in the global markets. First, there has a steady rise in the digitization of communication materials. This has led to a steady decline in the use of newsprint, directories, and certain printing and writing papers. This dynamic is still ongoing and is driven by the internet news services, smart-phones, electronic text books and similar modern trends. On the growth side, e-commerce is leading to a rise is packaging and corrugated products. Nonwoven fabrics, cellulose pulp and cement building products also are growing on a multi-year basis due to the suitability of these products in their applications. Lastly, there are certain products that are used in everyday life that track GDP activity and therefore tied to economic cycles. Currency exchange rates also are a factor in the behavior of global markets as many of the industries products are globally traded commodities and must be taken into account from time to time.

The markets the company serves are net growing and this data is available from a variety of industry sources. However, there are some notable declining and expanding situations beneath that overall outlook in the near term. Demand for the company’s products is growing in emerging geographies, tissue, pulp, nonwoven and fiber cement. Demand for the company’s products is contracting in newsprint and commodity products such as copy paper, directory paper, low-end cardboard, and certain mature geographies. The biggest declines are in sub-markets with declining demand, over-supply, low industry profitability and strong global currencies. In the near term, the market most in this condition is the United States.

In response to this, we will continue to move production to low cost countries and focus our research and development efforts on products that deliver increased value to our customers and for which they will pay value-based prices. In addition, we intend to continue to enhance and deploy our value added selling approach as part of our strategy to differentiate our products, while at the same time we remain focused on cost reduction and efficiency programs.

The negative paper industry trends described above are likely to continue in the near term. We believe that the paper industry will continue to experience an increased emphasis on product quality, annual cost reduction and machine uptime.

25


These underlying industry dynamics will impact our business, positively or negatively, and are comparative to alternate offerings from our competitors globally and within each geographic region.
Net Sales and Expenses
The following factors primarily drive net sales in both our clothing and roll covers segments:
the volume (tonnage) of worldwide paper production;
our ability to introduce new products that our customers value and will pay for;
advances in technology of our products, which can provide value to our customers by improving the efficiency of paper-making machines and reduce their manufacturing costs;
growth in developing markets, particularly in Asia;
the mix of paper grades being produced;
our ability to enter and expand our business in non-paper products; and
the impact of currency fluctuations.
  
  Net sales in our roll covers segment include our mechanical services business. We have expanded this business in response to demand from paper producers that we perform work on the internal mechanisms of their rolls while we refurbish or replace a roll cover. In our clothing segment, we conduct a small portion of our business pursuant to consignment arrangements; for these, we do not recognize a sale of a product to a customer until the customer places the product into use, which typically occurs some period after we ship the product to the customer or to a warehouse location near the customer’s facility. As part of the consignment agreement, we deliver the goods to a location designated by the customer. In addition, we agree to a “sunset” date with the customer, which represents the date by which the customer must accept all risks and responsibilities of ownership of the product and payment terms begin. For consignment sales, we recognize revenue on the earlier of the actual product installation date or the “sunset” date.
Our operating cost levels are impacted by total sales volume, raw material costs, the impact of inflation, foreign currency fluctuations and the success of our cost reduction programs.
The level of our cost of products sold is primarily attributable to labor costs, raw material costs, product shipping costs, plant utilization and depreciation, with labor costs constituting the largest component. We invest in facilities and equipment that enable innovative product development and improve production efficiency and costs. Recent examples of capital spending for such purposes include faster weaving looms and seaming machines with accurate electronic controls, automated compound mixing equipment and computer-controlled lathes and mills.
The level of research and development spending is driven by market demand for technology enhancements, including both specific customer needs and general market requirements, as well as by our own analysis of applied technology opportunities. With the exception of purchases of equipment and similar capital items used in our research and development activities, all research and development is expensed as incurred. Research and development expenses were $5,695 and $5,899 for the nine months ended September 30, 2015 and 2014, respectively.

Foreign Exchange
We have a geographically diverse customer base. In the nine months ended September 30, 2015, we generated approximately 39% of our net sales in North America, 32% in Europe, 19% in Asia-Pacific and 10% in South America.
A substantial portion of our net sales is denominated in Euros or other currencies. As a result, changes in the relative values of U.S. Dollars, Euros and other currencies affect our reported levels of net sales and profitability as the results are translated into U.S. Dollars for reporting purposes. In particular, decreases in the value of the U.S. Dollar relative to the value of the Euro and these other currencies positively impact our levels of revenue and profitability because the translation of a certain number of Euros or units of such other currencies into U.S. Dollars for financial reporting purposes will represent more U.S. Dollars than it would have prior to the relative decrease in the value of the U.S. Dollar. Conversely, a decline in the value of the Euro will result in a lower number of U.S. Dollars for financial reporting purposes.
For certain transactions, our net sales are denominated in U.S. Dollars, but all or a substantial portion of the associated costs are denominated in a different currency. As a result, changes in the relative values of U.S. Dollars, Euros and other currencies can affect the level of the profitability of these transactions. The largest proportion of such transactions consists of transactions in which the net sales are denominated in or indexed to the U.S. Dollar and all or a substantial portion of the associated costs are denominated in Brazilian Reals or other currencies.
During the nine months ended September 30, 2015, we conducted business in nine foreign currencies. The following table provides the average exchange rate for the nine months ended September 30, 2015 and 2014 of the U.S. Dollar against each of the four foreign currencies in which we conduct the largest portion of our operations.

26


 
Currency
  
Nine months ended September 30, 2015
  
Nine months ended September 30, 2014
Euro
  
$1.12 = 1 Euro
  
$1.36 = 1 Euro
Brazilian Real
  
$0.32 = 1 Brazilian Real
  
$0.44 = 1 Brazilian Real
Canadian Dollar
  
$0.80 = 1 Canadian Dollar
  
$0.91 = 1 Canadian Dollar
Australian Dollar
  
$0.76 = 1 Australian Dollar
  
$0.92 = 1 Australian Dollar
In the nine months ended September 30, 2015, we conducted approximately 33% of our operations in Euros, approximately 10% in the Australian Dollar, approximately 8% in the Brazilian Real (although a significant portion of Brazil net sales are in U.S. Dollars) and approximately 5% in the Canadian Dollar.
To mitigate the risk of transactions in which a sale is made in one currency and associated costs are denominated in a different currency, we may utilize forward currency contracts in certain circumstances to lock in exchange rates with the objective that the gain or loss on the forward contracts will approximate the loss or gain that results from the transaction or transactions being hedged. We determine whether to enter into hedging arrangements based upon the size of the underlying transaction or transactions, an assessment of the risk of adverse movements in the applicable currencies and the availability of a cost effective hedge strategy. To the extent we do not engage in hedging or such hedging is not effective, changes in the relative value of currencies can affect our profitability.

Domestic and Foreign Operating Results:
The following is an analysis of our domestic and foreign operations during the three and nine months ended September 30, 2015 and September 30, 2014 and a discussion of the results of operations during those periods (in thousands):
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
Domestic income (loss) from operations
$
803

 
$
5,067

 
$
(948
)
 
$
11,208

Foreign income from operations
8,583

 
12,724

 
38,096

 
31,493

Total income from operations
$
9,386

 
$
17,791

 
$
37,148

 
$
42,701

During the three and nine months ended September 30, 2015, domestic income from operations was lower than foreign income from operations primarily due to product mix, market differences and various unallocated corporate expenses. All earnings generated by foreign subsidiaries after 2012 will be remitted to the parent company at some point in the future. U.S. income taxes and foreign withholding taxes have been provided related to those foreign earnings. All other foreign unremitted earnings generated in years prior to 2013 will remain indefinitely reinvested, except for a portion of the earnings generated prior to 2013 related to our Brazil operations.
Cost Reduction Programs
An important part of our strategy is to seek to reduce our overall costs and improve our competitiveness. As a part of this effort, we engage in cost reduction programs, which are designed to improve the cost structure of our global operations in response to changing market conditions. These cost reduction programs include headcount reductions throughout the world as well as plant closures that are intended to rationalize production among our facilities to better enable us to match our cost structure with customer demand. Cost savings have been realized and are expected to be realized in labor costs and other production overhead, other components of costs of products sold, general and administrative expenses and facility costs. The majority of cost savings begin at the time of the headcount reductions and plant closure with remaining cost savings recognized over subsequent periods. Cost savings from headcount reductions have not been and are not expected to be offset by related increases in other expenses. Cost savings related to plant closures have been and are expected to be partially offset by additional costs incurred in the facilities that assumed the operations of the closed facility.
      
In October of 2015, we announced the permanent consolidation of our rolls manufacturing facility in Middletown, Virginia into other rolls manufacturing facilities. This closure will not affect the operations of our global rolls R&D center in Middletown. In fact, it will give the R&D team more room to accomplish product development and prototypes on next generation products. The time-line to complete this process is by the end of March of 2016. We accrued $0.7 million in severance charges in October of 2015 as a result of this consolidation.

27


In June of 2015, we announced that we had initiated closure proceedings with the representative union officials at our machine clothing facility in Warwick, Quebec, Canada in order to continue to address our cost structure. In the second and third quarters of 2015, we incurred $3.5 million in employee-related restructuring expenses. In addition, we recognized $1.0 million in impairment charges related to the building during the third quarter of 2015 related to this closure. The building is classified as held for sale in our Consolidated Condensed Balance Sheet at September 30, 2015.

For the nine months ended September 30, 2015, we incurred restructuring expenses of $12.7 million. These included $4.1 million of charges related to the closure of the Joao Pessoa, Brazil clothing facility, $4.5 million charges related to the closure of Warwick, Canada machine clothing facility, as described above, and $4.1 million of charges relating to headcount reductions and other costs related to previous plant closures. For the nine months ended September 30, 2014, we incurred restructuring expenses of $15.7 million. These included charges relating to headcount reductions of $4.2 million, $3.0 million relating to the closure of the Joao Pessoa, Brazil plant, $1.6 million relating to the termination of a sales agency contract in Italy, $2.2 million relating to the closures of machine clothing facilities in Argentina and Spain, $3.7 million relating to the closure of the Heidenheim facility, $0.7 million relating to the transfer of certain machinery and equipment from the closed France rolls facility to a China based rolls facility and other locations in Europe, and $0.3 million relating to the liquidation of the Vietnam facility.


Results of Operations

The table that follows sets forth for the periods presented certain consolidated operating results.
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
2015
 
2014
 
2015
 
2014
 
(in thousands)
 
(in thousands)
Net sales
$
117,739

 
$
138,858

 
$
361,896

 
$
411,965

Costs and expenses:
 
 
 
 
 
 
 
Cost of products sold
71,252

 
83,364

 
217,413

 
248,954

Selling
15,889

 
18,195

 
48,645

 
55,362

General and administrative
14,370

 
14,133

 
40,261

 
43,337

Research and development
1,841

 
1,909

 
5,695

 
5,899

Restructuring
5,001

 
3,466

 
12,734

 
15,712

 
108,353

 
121,067

 
324,748

 
369,264

Income from operations
9,386

 
17,791

 
37,148

 
42,701

Interest expense, net
(9,775
)
 
(9,412
)
 
(28,144
)
 
(26,985
)
Foreign exchange gain (loss)
2,059

 
367

 
2,150

 
(818
)
Income before provision for income taxes
1,670

 
8,746

 
11,154

 
14,898

Provision for income taxes
(755
)
 
(29,218
)
 
(9,209
)
 
(33,440
)
Net income (loss)
$
915

 
$
(20,472
)
 
$
1,945

 
$
(18,542
)
Comprehensive loss
$
(11,012
)
 
$
(41,003
)
 
$
(33,706
)
 
$
(39,482
)
Three Months Ended September 30, 2015 Compared to the Three Months Ended September 30, 2014
Net Sales. Net sales for the three months ended September 30, 2015 decreased by $(21.2) million, or (15.3)%, to $117.7 million from $138.9 million for the three months ended September 30, 2014. For the three months ended September 30, 2015, approximately 62% of our net sales were in our clothing segment and approximately 38% were in our roll covers segment.
In our clothing segment, net sales for the three months ended September 30, 2015 decreased $(13.6) million to $72.5 million from $86.1 million for the three months ended September 30, 2014. Excluding unfavorable currency effects of $(6.8) million, the remaining decrease was primarily due to the continued decline in the commodity grade markets in North America.
In our rolls segment, net sales for the three months ended September 30, 2015 decreased by $(7.6) million to $45.2 million from $52.8 million for the three months ended September 30, 2014. Excluding unfavorable currency effects of $(4.5) million, the decrease was primarily due to decreases in North America, as result of continued plant closures of commodity grade customers and decreased mechanical services sales. These decreases were partially offset by increases in Europe, as a result of improvements in the European market.

28


Cost of Products Sold. Cost of products sold for the three months ended September 30, 2015 decreased by $(12.1) million, or (14.5)%, to $71.3 million from $83.4 million for the three months ended September 30, 2014.
In our clothing segment, cost of products sold decreased $(8.1) million in the current quarter compared to the third quarter of 2014. This decrease was primarily due to favorable currency effects, decreased sales volume, and cost reduction programs, net of inflation, partially offset by unfavorable absorption as a result of the decline in production levels, unfavorable sales mix, plant startup costs and inventory write-offs at a closed plant. Cost of products sold as a percentage of net sales decreased by (0.2)% to 58.9% in the three months ended September 30, 2015 from 59.1% in the three months ended September 30, 2014. This decrease was primarily due to favorable currency effects, cost reduction programs, net of inflation, partially offset by unfavorable absorption, as a result of decreased production, unfavorable sales mix, increased plant startup costs and inventory write-offs at a closed plant.
In our rolls segment, cost of products sold decreased $(4.0) million in the current quarter compared to the third quarter of 2014, primarily as a result of favorable currency effects, decreased sales volume and cost reduction programs, net of inflation, partially offset by plant startup costs. Cost of products sold as a percentage of net sales increased by 1.5% to 63.0% for the three months ended September 30, 2015 from 61.5% for the three months ended September 30, 2014, primarily as a result of unfavorable currency effects, partially offset by our cost reduction programs.
Selling Expenses. For the three months ended September 30, 2015, selling expenses decreased by $(2.3) million, or (12.6)%, to $15.9 million from $18.2 million for the three months ended September 30, 2014. This decrease was primarily driven by favorable currency effects and decreased sales volumes.

General and Administrative Expenses. For the three months ended September 30, 2015, general and administrative expenses increased by $0.3 million, or 2.1%, to $14.4 million from $14.1 million for the three months ended September 30, 2014, primarily as a result of inflationary increases, increased bad debt charges as a result of mill closures and incremental costs from the deferred refinancing transaction, offset by favorable currency effects, operational excellence programs and decreased management incentives.

Restructuring Expenses. For the three months ended September 30, 2015, we incurred restructuring expenses of $5.0 million. These included $1.2 million of charges related to the closure of the Joao Pessoa, Brazil clothing facility, $2.1 million charges related to the closure of Warwick, Canada machine clothing facility, as described above, and $1.7 million of charges relating to headcount reductions and other costs related to previous plant closures.
Interest Expense, Net. Net interest expense for the three months ended September 30, 2015 was $9.8 million, up $0.4 million from $9.4 million for the three months ended September 30, 2014. The increase was primarily due to increased average debt balances to fund capital expenditures.
Provision for Income Taxes. For the three months ended September 30, 2015 and 2014, the provision for income taxes was $0.8 million and $29.2 million, respectively. The decrease in tax expense in the three months ended September 30, 2015, was primarily attributable to a release of valuation allowance against Australian deferred tax assets, along with decreased earnings in 2015, compared to a tax provision recorded in 2014 related to settling a tax assessment in Brazil. Generally, our provision for income taxes is primarily impacted by the income we earn in tax paying jurisdictions relative to the income we earn in non-tax paying jurisdictions. The majority of income recognized for purposes of computing our effective tax rate is earned in countries where the statutory income tax rates range from 15% to 36%. However, permanent income adjustments recorded against pre-tax earnings may result in an effective tax rate that is higher or lower than the statutory tax rate in these jurisdictions. We generate losses in certain jurisdictions for which we realize no tax benefit as the deferred tax assets in these jurisdictions (including net operating losses) are fully reserved in our valuation allowance. For this reason, we recognize minimal income tax expense or benefit in these jurisdictions, of which the most material jurisdictions are the United States and Australia. Due to these reserves, the geographic mix of our pre-tax earnings has a direct correlation with how high or low our annual effective tax rate is relative to consolidated earnings.
Nine Months Ended September 30, 2015 Compared to the Nine Months Ended September 30, 2014
Net Sales. Net sales for the nine months ended September 30, 2015 decreased by $(50.1) million, or (12.2)%, to $361.9 million from $412.0 million for the nine months ended September 30, 2014. For the nine months ended September 30, 2015, approximately 63% of our net sales were in our clothing segment and approximately 37% were in our roll covers segment.
In our clothing segment, net sales for the nine months ended September 30, 2015 decreased $(35.6) million to $229.0 million from $264.6 million for the nine months ended September 30, 2014. Excluding unfavorable currency effects of $(22.0)

29


million, the remaining decrease was primarily due to the continued decline in the commodity grade markets in North America and decreased sales in Asia.
In our rolls segment, net sales for the nine months ended September 30, 2015 decreased by $(14.5) million to $132.9 million from $147.4 million for the nine months ended September 30, 2014. Excluding unfavorable currency effects of $(13.0) million, roll cover sales decreased $(1.5) million, primarily due to decreases in North America, as result of continued plant closures of commodity grade customers and reduced mechanical services sales. These decreases were partially offset by increases in rolls sales volumes in Europe.
Cost of Products Sold. Cost of products sold for the nine months ended September 30, 2015 decreased by $(31.6) million, or (12.7)%, to $217.4 million from $249.0 million for the nine months ended September 30, 2014.
In our clothing segment, cost of products sold decreased $(22.9) million in the nine months ended September 30, 2015 compared to the nine months ended September 30, 2014. This decrease was primarily due to favorable currency effects, decreased sales volume, cost reduction programs, net of inflation, partially offset by unfavorable absorption as a result of the decline in production levels, unfavorable sales mix, plant startup costs and inventory write-offs at a closed plant. Cost of products sold as a percentage of net sales decreased by (0.9)% to 57.8% in the nine months ended September 30, 2015 from 58.7% in the nine months ended September 30, 2014. This decrease was primarily due to favorable currency effects and cost reduction programs, net of inflation, partially offset by unfavorable absorption, as a result of decreased production, unfavorable sales mix, increased plant startup costs and inventory write-offs at a closed plant.
In our rolls segment, cost of products sold decreased $(8.6) million in the nine months ended September 30, 2015 compared to the nine months ended September 30, 2014, primarily as a result of favorable currency effects, decreased sales volume and cost reduction programs, net of inflation, partially offset by plant startup costs. Cost of products sold as a percentage of net sales increased by 1.5% to 64.1% for the nine months ended September 30, 2015 from 63.6% for the nine months ended September 30, 2014, primarily as a result of unfavorable currency effects and increased plant startup costs, partially offset by our cost reduction programs, net of inflation.
Selling Expenses. For the nine months ended September 30, 2015, selling expenses decreased by $(6.8) million, or (12.3%), to $48.6 million from $55.4 million for the nine months ended September 30, 2014. This decrease was primarily driven by favorable currency effects and decreased sales volumes.

General and Administrative Expenses. For the nine months ended September 30, 2015, general and administrative expenses decreased by $(3.0) million, or (6.9)%, to $40.3 million from $43.3 million for the nine months ended September 30, 2014, primarily as a result of favorable currency effects, cost reduction efforts and a decrease in management incentive compensation. These decreases were partially offset by inflationary increases and incremental charges related to a deferred refinancing transaction.
Restructuring Expenses. For the nine months ended September 30, 2015, we incurred restructuring expenses of $12.7 million. These included $4.1 million of charges related to the closure of the Joao Pessoa, Brazil clothing facility, $4.5 million charges related to the closure of Warwick, Canada machine clothing facility, as described above, and $4.1 million of charges relating to headcount reductions and other costs relating to previous plant closures.
Interest Expense, Net. Net interest expense for the nine months ended September 30, 2015 was $28.1 million, up $1.1 million from $27.0 million for the nine months ended September 30, 2014. Increases were primarily due to increased average borrowings from 2014 to 2015, primarily as a result of the Brazilian tax payment made in August of 2014 and capital expenditures.
Provision for Income Taxes. For the nine months ended September 30, 2015 and 2014, the provision for income taxes was $9.2 million and $33.4 million, respectively. The decrease in tax expense in the nine months ended September 30, 2015, was primarily attributable to a release in valuation allowance against Australian deferred tax assets partially offset by an increase in the unrecognized tax benefit due to the effects of income tax audits in 2015, compared to a tax provision recorded in 2014 related to settling a tax assessment in Brazil, along with the geographic mix of earnings. Generally, our provision for income taxes is primarily impacted by the income we earn in tax paying jurisdictions relative to the income we earn in non-tax paying jurisdictions. The majority of income recognized for purposes of computing our effective tax rate is earned in countries where the statutory income tax rates range from 15% to 36%. However, permanent income adjustments recorded against pre-tax earnings may result in an effective tax rate that is higher or lower than the statutory tax rate in these jurisdictions. We generate losses in certain jurisdictions for which we realize no tax benefit as the deferred tax assets in these jurisdictions (including net operating losses) are fully reserved in our valuation allowance. For this reason, we recognize minimal income tax expense or benefit in these jurisdictions, of which the most material jurisdictions are the United States and Australia. Due to

30


these reserves, the geographic mix of our pre-tax earnings has a direct correlation with how high or low our annual effective tax rate is relative to consolidated earnings.
Liquidity and Capital Resources
Our principal liquidity requirements are for debt service, restructuring payments, working capital and capital expenditures. We plan to use cash on hand, cash generated by operations and our revolving credit facility, as our primary sources of liquidity. Our operations are highly dependent upon the paper production industry and the degree to which the paper industry is affected by global economic conditions and the availability of credit. Demand for our products could decline if paper manufacturers are unable to obtain required financing or if economic conditions cause additional mill closures. In addition, an economic recession or unavailability of credit may affect our customers’ ability to pay their debts.
Net cash provided by operating activities was $24.9 million for the nine months ended September 30, 2015 and $1.3 million for the nine months ended September 30, 2014. The $23.6 million increase was primarily due to the Brazilian tax payment made in 2014, partially offset by an increase in working capital in 2014 that did not occur in 2015.
Net cash used in investing activities was $40.3 million for the nine months ended September 30, 2015 and $33.5 million for the nine months ended September 30, 2014. The increase in cash used in investing activities of $6.8 million was primarily due to the increase in capital expenditures.
Net cash provided by financing activities was $17.7 million and $26.7 million for the nine months ended September 30, 2015 and 2014, respectively. The decrease of $(9.0) million was primarily the result of the decrease of $(10.1) million in net borrowings and an increase of $0.3 million in payments under capital leases, partially offset by a decrease in the payment of financing fees of $(1.4) million.
As of September 30, 2015, the outstanding balance of the Company's term debt under its Credit Facility and Notes was $460.9 million, which is net of a $0.7 million discount. In addition, as of September 30, 2015, an aggregate of $33.0 million is available for additional borrowings. This availability represents a borrowing base of $44.6 million less $11.6 million of that facility committed for letters of credit or additional borrowings.
We expect to spend cash of approximately $13.0 million related to our restructuring initiatives in 2015. We have spent $10.3 million in the nine months ended September 30, 2015. Actual restructuring costs for 2015 may substantially differ from estimates at this time, depending on the timing of the restructuring activities and the required actions to complete them.
New Machine Clothing and Rolls Facilities
Our Kunshan, China press felt plant recently began production. This two year, $47.8 million greenfield project is a brand-new press felt facility located in the center of the largest paper-making region in the world. This facility significantly improves our competitive positioning, from both a lead time and cost perspective, enabling us to more closely partner with customers who were previously served from our European facilities. We will conduct business in local currency and local languages and will be able to service the largest pulp, paper, paperboard, and tissue machines in the world. For some press felt designs, Xerium will be able to make 3 pieces simultaneously - a first for Xerium.
Our $4.3 million Corlu, Turkey Rolls facility was commissioned in July and we will continue to ramp production capabilities at this greenfield facility throughout the third quarter of 2015. This facility will act as a new regional hub serving customers in Turkey, Southeast Europe and the Middle East. We have conducted business in these regions for many decades as an exporter, and now will serve as a local low-cost provider with shortened lead times to customers. The plant has one of the largest grinding machines in the region and was built to handle rolls up to 80 metric tonnes in weight. For the first time ever customers in this under-served region will receive locally provided and locally optimized state-of -the-art rubber extrusion and polyurethane roll covering technology.
Capital Expenditures
For the nine months ended September 30, 2015, we had capital expenditures of $40.4 million. We are currently targeting capital expenditures for 2015 to be approximately $50.0 million. We analyze our planned capital expenditures, based on investment opportunities available to us and our financial and operating performance, and accordingly, actual capital expenditures may be more or less than this amount. We intend to use existing cash and cash from operations to fund our capital expenditures.
See “Credit Facility and Notes” below for a description on limitations on capital expenditures imposed by our Credit Facility.

31



Credit Facility and Notes

On November 3, 2015, the we refinanced our existing ABL Facility and entered into a new Revolving Credit and Guaranty Agreement (as amended, the "New ABL Facility") with one of our existing ABL lenders, JPMorgan Chase Bank, N.A.   Under the New ABL Facility, JPMorgan will become the lead domestic agent and will continue as the European agent.  The amount of the ABL Facility will continue to provide aggregate availability of $55 million and the collateral pledged thereunder will also remain the same, however the New ABL Facility (1) provides increased flexibility for operations; (2) an extended maturity date of November, 2020; and (3) lower interest rates.
On July 17, 2015, Xerium China, Co., Ltd. ("Xerium China"), a wholly-owned subsidiary of the Company closed a Fixed Assets Loan Contract (the "Loan Agreement") with the Industrial and Commercial Bank of China Limited, Shanghai-Jingan Branch with respect to a RMB 58.5 million loan, which was approximately $9.4 million USD on July 17, 2015, based on an exchange rate of 6.21 RMB per 1.00 USD. The loan is secured by pledged machinery and equipment of Xerium China and guaranteed by Xerium Asia Pacific (Shanghai) Limited and Stowe Woodward (Changzhou) Roll Technologies Co. Ltd., which are wholly-owned subsidiaries of the Company, pursuant to guarantee agreements (the "Guarantee Agreements"). Interest on the outstanding principal balance of the loan accrues at a benchmark rate plus a margin. The benchmark rate is the benchmark interest rate as published by the People's Bank of China on June 28, 2015 which was 5.25%. The margin is set at 10% for the entire loan period, with the current interest rate at 5.78%. The interest rate will be adjusted every 12 months during the term of the loan, based on the benchmark interest rate adjustment. Interest under the loan is payable quarterly in arrears. Principal on the loan is to be repaid in part every six months following the Closing Date, in accordance with a predetermined schedule set forth in the Loan Agreement. Proceeds of the Loan will be used by Xerium China to purchase production equipment. The Loan Agreement contains certain customary representations and warranties and provisions relating to events of default.
On May 17, 2013, the Company entered into a Credit and Guaranty Agreement for a $200.0 million term loan credit facility (the “Term Credit Facility”), net of a discount of $1.0 million, among the Company, certain direct and indirect U.S. subsidiaries of the Company as guarantors and certain financial institutions. The Company also entered into a Revolving Credit and Guaranty Agreement originally for a $40.0 million asset-based revolving credit facility subject to a borrowing base among Xerium Technologies, Inc, as a US borrower, Xerium Canada Inc., as Canadian borrower, certain direct and indirect U.S. subsidiaries of the Company as guarantors and certain financial institutions (the "Domestic Revolver"). On March 3, 2014, the Company entered into an amendment to the Revolving Credit and Guaranty Agreement (as amended, the “ABL Facility,” and collectively with the Term Credit Facility, the “Credit Facility”) to add the Company's German subsidiaries as European Borrowers (the "European Borrowers") and to provide for an additional $15 million European asset-based revolving credit facility subject to a European borrowing base (the "European Revolver"), increasing the aggregate availability under the ABL Facility to $55 million.
On August 18, 2014, the Company entered into the Second Amendment to Credit and Guaranty Agreement (the “Second Amendment”). Under the Second Amendment, the Company borrowed an additional $30.0 million by utilizing the Incremental Facility. The $30 million in additional borrowings was used to finance a tax amnesty payment in Brazil. The Second Amendment made no changes to the repayment and other previously disclosed terms of the Credit Facility.
The Credit Facility contains certain customary covenants that, subject to exceptions, restrict our ability to, among other things:
declare dividends or redeem or repurchase equity interests;
prepay, redeem or purchase debt;
incur liens and engage in sale-leaseback transactions;
make loans and investments;
incur additional indebtedness;
amend or otherwise alter debt and other material agreements;
make capital expenditures in excess of $42 million per fiscal year, subject to adjustment;
engage in mergers, acquisitions and asset sales;
transact with affiliates; and
engage in businesses that are not related to the Company's existing business.
We are in compliance with all covenants under the Notes and Credit Facility at September 30, 2015.

     
Critical Accounting Policies

32


The condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). The preparation of financial statements in conformity with GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses. Actual results could differ from those estimates.
Our significant policies are described in the notes to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014. Judgments and estimates of uncertainties are required in applying our accounting policies in many areas. There have been no material changes to the critical accounting policies affecting the application of those accounting policies as noted in our Annual Report on Form 10-K for the year ended December 31, 2014.
Non-GAAP Financial Measures
We use EBITDA and Adjusted EBITDA (each as defined in the Credit Facility) as supplementary non-GAAP liquidity measures to assist us in evaluating our liquidity and financial performance, specifically our ability to service indebtedness and to fund ongoing capital expenditures. Neither EBITDA nor Adjusted EBITDA should be considered in isolation or as a substitute for income from operations or cash flows (as determined in accordance with GAAP).
EBITDA is defined as net income before interest expense, income tax provision and depreciation (including non-cash impairment charges) and amortization.
“Adjusted EBITDA” means, with respect to any period, the total of (A) the consolidated net income for such period, plus (B) without duplication, to the extent that any of the following were deducted in computing such consolidated net income for such period: (i) provision for taxes based on income or profits, including, without limitation, federal, state, provincial, franchise and similar taxes, including any penalties and interest relating to any tax examinations, (ii) consolidated interest expense, (iii) consolidated depreciation and amortization expense, (iv) reserves for inventory in connection with plant closures, (v) consolidated operational restructuring costs, (vi) non-cash charges resulting from the application of purchase accounting, including push-down accounting, (vii) non-cash expenses resulting from the granting of common stock, stock options, restricted stock or restricted stock unit awards under equity compensation programs solely with respect to common stock, and cash expenses for compensation mandatorily applied to purchase common stock, (viii) non-cash items relating to a change in or adoption of accounting policies, (ix) non-cash expenses relating to pension or benefit arrangements, (x) expenses incurred as a result of the repurchase, redemption or retention of common stock earned under equity compensation programs solely in order to make withholding tax payments, (xi) amortization or write-offs of deferred financing costs, (xii) any non-cash losses resulting from mark to market hedging obligations (to the extent the cash impact resulting from such loss has not been realized in such period) and (xiii) other non-cash losses or charges (excluding, however, any non-cash loss or charge which represents an accrual of, or a reserve for, a cash disbursement in a future period), minus (C) without duplication, to the extent any of the following were included in computing consolidated net income for such period, (i) non-cash gains with respect to the items described in clauses (vi), (vii), (ix), (xi), (xii) and (xiii) (other than, in the case of clause (xiii), any such gain to the extent that it represents a reversal of an accrual of, or reserve for, a cash disbursement in a future period) of clause (B) above and (ii) provisions for tax benefits based on income or profits. Notwithstanding the foregoing, Adjusted EBITDA, as defined in the Credit Facility and calculated below, may not be comparable to similarly titled measurements used by other companies.
Consolidated net income is defined as net income determined on a consolidated basis in accordance with GAAP; provided, however, that the following, without duplication, shall be excluded in determining consolidated net income: (i) any net after-tax extraordinary or non-recurring gains, losses or expenses (less all fees and expenses relating thereto), (ii) the cumulative effect of changes in accounting principles, (iii) any fees and expenses incurred during such period in connection with the issuance or repayment of indebtedness, any refinancing transaction or amendment or modification of any debt instrument, in each case, as permitted under the Credit Facility and (iv) any cancellation of indebtedness income.
The following table provides reconciliation from net income and operating cash flows, which are the most directly comparable GAAP financial measures, to EBITDA and Adjusted EBITDA.

33


 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
Net income (loss)
$
915

 
$
(20,472
)
 
$
1,945

 
$
(18,542
)
Stock-based compensation
1,064

 
709

 
2,690

 
1,858

Depreciation
7,138

 
8,183

 
21,397

 
24,950

Amortization of intangibles
69

 
231

 
228

 
1,230

Deferred financing cost amortization
870

 
942

 
2,641

 
2,409

Foreign exchange (gain) loss on revaluation of debt
(1,200
)
 
396

 
(2,115
)
 
(340
)
Deferred tax expense
(3,179
)
 
2,460

 
(1,571
)
 
1,509

Asset impairment
1,135

 
277

 
1,178

 
277

Gain on disposition of property and equipment
(69
)
 
(33
)
 
(85
)
 
(4
)
Net change in operating assets and liabilities
3,441

 
(292
)
 
(1,452
)
 
(12,030
)
Net cash provided by (used in) operating activities
10,184

 
(7,599
)
 
24,856

 
1,317

Interest expense, excluding amortization
8,905

 
8,650

 
25,503

 
24,576

Net change in operating assets and liabilities
(3,441
)
 
292

 
1,452

 
12,030

Current portion of income tax expense
3,934

 
26,758

 
10,780

 
31,931

Stock-based compensation
(1,064
)
 
(709
)
 
(2,690
)
 
(1,858
)
Foreign exchange gain (loss) on revaluation of debt
1,200

 
(396
)
 
2,115

 
340

Asset impairment
(1,135
)
 
(277
)
 
(1,178
)
 
(277
)
Loss on disposition of property and equipment
69

 
33

 
85

 
4

EBITDA
18,652

 
26,752

 
60,923

 
68,063

Stock-based compensation
1,064

 
709

 
2,690

 
1,858

Operational restructuring expenses
5,001

 
3,466

 
12,734

 
15,712

Inventory write-offs related to plant closures
465

 

 
465

 

Impairment of idle equipment
149

 

 
149

 

Other non-recurring expenses
1,552

 

 
2,402

 

Plant startup costs
1,378

 
537

 
3,110

 
953

Adjusted EBITDA
$
28,261

 
$
31,464

 
$
82,473

 
$
86,586




ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk
Our interest rate risks as of September 30, 2015 have not materially changed from December 31, 2014 (see Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2014). As of September 30, 2015, we had outstanding debt with a carrying amount of $484.3 million with an approximate fair value of $486.7 million.
Foreign Currency Risk
As discussed in Note 6 to the Consolidated Financial Statements, the Euro, the Brazilian Real and the Canadian Dollar declined significantly from December 31, 2014. These declines had an unfavorable impact of approximately $(40,701) on our foreign subsidiaries net equity balances at September 30, 2015.

 
ITEM 4.
CONTROLS AND PROCEDURES
(a) Evaluation of Disclosure Controls and Procedures. We have carried out an evaluation, as of September 30, 2015 under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules

34


13a–15(e) and 15d–15(e) under the Securities Exchange Act of 1934, as amended (the “Act”). Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Act is (i) recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms; and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosures. No evaluation of disclosure controls and procedures can provide absolute assurance that these controls and procedures will operate effectively under all circumstances. However, our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives, and our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures are effective at the reasonable assurance level as set forth above.
(b) Changes in Internal Control over Financial Reporting. No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Act) occurred during the quarter ended September 30, 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
 
ITEM 1.
LEGAL PROCEEDINGS
There have been no material developments to the legal proceedings described in our Annual Report on Form 10-K for the year ended December 31, 2014. See Note 9 to our Unaudited Condensed Consolidated Financial Statements for other routine litigation to which we are subject.

ITEM 1A.
RISK FACTORS
The risks described in our Annual Report on Form 10-K for the year ended December 31, 2014 have not materially changed.
       
ITEM 6.    EXHIBITS
See the exhibit index following the signature page to this Quarterly Report on Form 10-Q.
 

35




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
 
XERIUM TECHNOLOGIES, INC.
 
(Registrant)
 
 
 
November 4, 2015
By:              
/s/Clifford E. Pietrafitta
 
 
Clifford E. Pietrafitta
 
 
Executive Vice President and CFO
 
 
(Principal Financial Officer)


36



EXHIBIT INDEX
 
Exhibit  
Number   
 
Description of Exhibits
 
 
31.1
 
Certification Statement of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
31.2
 
Certification Statement of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
32.1
 
Certification Statement of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
32.2
 
Certification Statement of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
101.INS
 
XBRL Instance Document
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document







37